Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to d...
Saved in:
| Published in | Diabetologia Vol. 52; no. 1; pp. 17 - 30 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Berlin/Heidelberg
Springer-Verlag
01.01.2009
Springer Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0012-186X 1432-0428 1432-0428 |
| DOI | 10.1007/s00125-008-1157-y |
Cover
| Abstract | The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm published in January 2008 specifically addressed safety issues surrounding the thiazolidinediones. In this revision, we focus on the new classes of medications that now have more clinical data and experience. |
|---|---|
| AbstractList | The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm published in January 2008 specifically addressed safety issues surrounding the thiazolidinediones. In this revision, we focus on the new classes of medications that now have more clinical data and experience. [PUBLICATION ABSTRACT] The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm published in January 2008 specifically addressed safety issues surrounding the thiazolidinediones. In this revision, we focus on the new classes of medications that now have more clinical data and experience. The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm published in January 2008 specifically addressed safety issues surrounding the thiazolidinediones. In this revision, we focus on the new classes of medications that now have more clinical data and experience.The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm published in January 2008 specifically addressed safety issues surrounding the thiazolidinediones. In this revision, we focus on the new classes of medications that now have more clinical data and experience. |
| Author | Holman, R. R. Ferrannini, E. Sherwin, R. Nathan, D. M. Davidson, M. B. Buse, J. B. Zinman, B. |
| Author_xml | – sequence: 1 givenname: D. M. surname: Nathan fullname: Nathan, D. M. email: dnathan@partners.org organization: Diabetes Center, Massachusetts General Hospital – sequence: 2 givenname: J. B. surname: Buse fullname: Buse, J. B. organization: University of North Carolina School of Medicine – sequence: 3 givenname: M. B. surname: Davidson fullname: Davidson, M. B. organization: Clinical Center for Research Excellence, Charles R. Drew University – sequence: 4 givenname: E. surname: Ferrannini fullname: Ferrannini, E. organization: Department of Internal Medicine, University of Pisa – sequence: 5 givenname: R. R. surname: Holman fullname: Holman, R. R. organization: Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University – sequence: 6 givenname: R. surname: Sherwin fullname: Sherwin, R. organization: Department of Internal Medicine and Yale Center for Clinical Investigation, Yale University School of Medicine – sequence: 7 givenname: B. surname: Zinman fullname: Zinman, B. organization: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21091994$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18941734$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kc1u1DAUhS1URKeFB2CDLCTYBfyTxA67qqKAVMSmC3bWHftmxqPEGWxnkT0PjqczLVIlWFm6_o597jkX5CxMAQl5zdkHzpj6mBjjoqkY0xXnjaqWZ2TFaykqVgt9RlaH64rr9uc5uUhpxxiTTd2-IOdcdzVXsl6R39_ReQsDHSHABkcMmU493S57jJthsYCjB-oDzWVCBXUe1pgx0RGHwec5faJA7RQShjQnCsNmij5vR9pPkeYtFqnPHrKfAoXgKLjdnPLDNwWIsF9ekuc9DAlfnc5Lcnfz-e76a3X748u366vbykrR5UoAE03NBGrlQEmpnMBWo2wdAw5W2d7aWuumc65T6GTTrYXgDNt1Z1nby0vy_vjsPk6_ZkzZjD7ZsgcEnOZk2lZJoaUu4Nsn4G6aYyjWjOBS103T1gV6c4Lm9YjO7KMfIS7mIdsCvDsBkErCfYRgfXrkirOOd92BU0fOximliL2xPt8nliP4wXBmDm2bY9umtG0ObZulKPkT5aOJ_2jEUZMKGzYY_-72b9Ef9K29tA |
| CitedBy_id | crossref_primary_10_1007_s13300_013_0024_0 crossref_primary_10_1111_j_1463_1326_2011_01523_x crossref_primary_10_3390_pharmaceutics9040040 crossref_primary_10_2337_dc09_S315 crossref_primary_10_1111_dme_13859 crossref_primary_10_1016_j_clinthera_2016_05_001 crossref_primary_10_1016_j_jamda_2013_08_002 crossref_primary_10_1155_2014_575124 crossref_primary_10_4236_jbise_2024_1711020 crossref_primary_10_1016_j_diabet_2009_11_006 crossref_primary_10_1089_dia_2014_0261 crossref_primary_10_2337_dc09_1488 crossref_primary_10_1586_eem_11_23 crossref_primary_10_1016_j_endonu_2012_11_009 crossref_primary_10_1016_j_pcd_2009_05_002 crossref_primary_10_1016_j_phrs_2019_01_036 crossref_primary_10_1586_eem_10_59 crossref_primary_10_1007_s00125_009_1301_3 crossref_primary_10_1038_nrc3397 crossref_primary_10_3390_nu8070443 crossref_primary_10_1517_14656566_2011_568477 crossref_primary_10_3390_diagnostics14192132 crossref_primary_10_1007_s12170_010_0115_7 crossref_primary_10_52711_2231_5675_2024_00042 crossref_primary_10_1371_journal_pone_0121553 crossref_primary_10_1016_j_diabres_2017_01_002 crossref_primary_10_1021_jf3032556 crossref_primary_10_1097_MOL_0b013e3283321d37 crossref_primary_10_1158_0008_5472_CAN_17_1903 crossref_primary_10_1007_s11695_019_03901_9 crossref_primary_10_1007_s11255_017_1548_4 crossref_primary_10_1111_j_1463_1326_2012_01586_x crossref_primary_10_1097_MD_0000000000008161 crossref_primary_10_5402_2012_798146 crossref_primary_10_1002_pdi_1365 crossref_primary_10_1179_2045772312Y_0000000034 crossref_primary_10_3233_MNM_17160 crossref_primary_10_1002_pds_3801 crossref_primary_10_1016_j_jep_2013_09_027 crossref_primary_10_1007_s00592_012_0442_x crossref_primary_10_1186_s12886_022_02608_3 crossref_primary_10_2217_dmt_12_42 crossref_primary_10_1111_jep_12286 crossref_primary_10_1007_s00125_010_1986_3 crossref_primary_10_1007_s11892_011_0179_x crossref_primary_10_1016_j_dsx_2015_10_010 crossref_primary_10_1007_s00125_012_2584_3 crossref_primary_10_2337_db13_0194 crossref_primary_10_1517_14656566_2012_667078 crossref_primary_10_1111_j_1755_6686_2010_00175_x crossref_primary_10_2165_11585300_000000000_00000 crossref_primary_10_1016_j_ejphar_2016_07_012 crossref_primary_10_2337_dc22_1253 crossref_primary_10_1093_qjmed_hcp168 crossref_primary_10_1517_17425255_2010_513699 crossref_primary_10_2337_dc13_0512 crossref_primary_10_1007_s15034_012_0023_7 crossref_primary_10_1186_cc11663 crossref_primary_10_1016_j_medcli_2009_11_022 crossref_primary_10_3389_fneur_2021_648907 crossref_primary_10_1016_j_biopha_2022_113405 crossref_primary_10_1016_j_jstrokecerebrovasdis_2016_09_012 crossref_primary_10_1111_j_1463_1326_2011_01416_x crossref_primary_10_1016_S0084_3741_10_79453_1 crossref_primary_10_1007_s13340_016_0263_1 crossref_primary_10_1186_1741_7015_9_76 crossref_primary_10_2147_VHRM_S345810 crossref_primary_10_1007_s00125_010_1767_z crossref_primary_10_1007_s00125_013_2991_0 crossref_primary_10_1111_j_1742_7924_2012_00218_x crossref_primary_10_1016_j_clinthera_2012_12_002 crossref_primary_10_1172_JCI38817 crossref_primary_10_1007_s13300_020_00926_7 crossref_primary_10_1002_14651858_CD012368 crossref_primary_10_1002_pdi_1370 crossref_primary_10_1111_j_1463_1326_2010_01262_x crossref_primary_10_1155_2019_1341963 crossref_primary_10_3109_07853890_2012_699715 crossref_primary_10_1517_14656566_2011_628936 crossref_primary_10_1016_j_diabres_2015_12_011 crossref_primary_10_1016_j_dld_2010_02_004 crossref_primary_10_1016_j_regpep_2010_05_008 crossref_primary_10_1007_s00125_009_1358_z crossref_primary_10_1016_S0140_6736_12_60439_5 crossref_primary_10_3390_ijerph182211955 crossref_primary_10_1517_14656560903176453 crossref_primary_10_1517_14740338_2011_583234 crossref_primary_10_1111_j_1463_1326_2009_01079_x crossref_primary_10_1186_1472_6823_11_17 crossref_primary_10_1016_j_jchromb_2014_06_023 crossref_primary_10_18410_jebmh_2016_503 crossref_primary_10_4239_wjd_v3_i9_158 crossref_primary_10_1007_s10549_012_2170_x crossref_primary_10_1016_j_soard_2011_05_013 crossref_primary_10_1016_S0140_6736_10_60632_0 crossref_primary_10_1089_dia_2010_0184 crossref_primary_10_1093_qjmed_hcq127 crossref_primary_10_14341_2072_0351_3761 crossref_primary_10_1111_bcp_12453 crossref_primary_10_1007_s11892_011_0220_0 crossref_primary_10_1016_j_ando_2012_06_002 crossref_primary_10_1507_endocrj_EJ12_0068 crossref_primary_10_4161_21623945_2014_983752 crossref_primary_10_1007_s10354_011_0889_3 crossref_primary_10_1007_s00125_015_3766_6 crossref_primary_10_1111_j_2040_1124_2010_00022_x crossref_primary_10_1016_S0140_6736_12_60283_9 crossref_primary_10_1002_dmrr_973 crossref_primary_10_1007_s12020_014_0474_9 crossref_primary_10_1016_S1957_2557_10_70036_5 crossref_primary_10_1007_s11428_011_0697_9 crossref_primary_10_1210_jc_2012_3042 crossref_primary_10_4140_TCP_sB_2009_002 crossref_primary_10_1111_ijcp_12847 crossref_primary_10_1007_s40265_021_01554_6 crossref_primary_10_1111_j_1365_2710_2009_01154_x crossref_primary_10_1016_j_regpep_2010_04_003 crossref_primary_10_1210_jc_2012_3034 crossref_primary_10_1016_S1575_0922_10_70001_2 crossref_primary_10_2478_v10255_012_0049_6 crossref_primary_10_1016_j_jcjd_2013_07_030 crossref_primary_10_1016_S1751_9918_10_60005_8 crossref_primary_10_1016_j_clp_2019_02_005 crossref_primary_10_2147_CMAR_S305321 crossref_primary_10_1177_1474651412450477 crossref_primary_10_9778_cmajo_20130073 crossref_primary_10_1007_s10549_018_05070_2 crossref_primary_10_1016_j_biochi_2017_08_001 crossref_primary_10_1186_1472_6823_14_23 crossref_primary_10_1016_j_jtumed_2018_02_009 crossref_primary_10_1902_jop_2009_080664 crossref_primary_10_1586_eem_11_98 crossref_primary_10_3109_13814788_2013_847083 crossref_primary_10_1007_s12032_013_0590_z crossref_primary_10_1111_j_2040_1124_2010_00025_x crossref_primary_10_1002_jcla_20503 crossref_primary_10_1097_QMH_0b013e31826d1ef9 crossref_primary_10_1534_g3_113_006437 crossref_primary_10_1016_S1957_2557_11_70055_4 crossref_primary_10_1097_01_NPR_0000451880_48790_50 crossref_primary_10_1111_j_1464_5491_2011_03306_x crossref_primary_10_1517_17425250902806424 crossref_primary_10_1097_CEJ_0000000000000235 crossref_primary_10_31829_2641_7456_ahs2020_4_1__118 crossref_primary_10_1016_j_bmc_2013_04_004 crossref_primary_10_1016_j_bmcl_2021_128447 crossref_primary_10_1186_s13287_019_1480_x crossref_primary_10_1016_j_avdiab_2012_07_001 crossref_primary_10_1016_j_hoc_2013_05_009 crossref_primary_10_1007_s00125_009_1257_3 crossref_primary_10_1016_S1957_2557_19_30057_4 crossref_primary_10_1016_j_jdiacomp_2011_06_004 crossref_primary_10_1016_j_medcli_2009_02_001 crossref_primary_10_2337_dcS13_2007 crossref_primary_10_1007_s11845_020_02320_5 crossref_primary_10_2337_dc11_s217 crossref_primary_10_2337_dc11_s215 crossref_primary_10_2337_dc11_s231 crossref_primary_10_1177_1479164112475102 crossref_primary_10_1515_jpem_2010_163 crossref_primary_10_1007_s12020_012_9596_0 crossref_primary_10_1111_j_1742_1241_2009_02086_x crossref_primary_10_1007_s00125_009_1409_5 crossref_primary_10_1186_cc11332 crossref_primary_10_1007_s40267_022_00903_z crossref_primary_10_4236_jdm_2012_21016 crossref_primary_10_1007_s00125_010_1906_6 crossref_primary_10_1007_s00125_018_4547_9 crossref_primary_10_1177_193229681100500401 crossref_primary_10_1111_j_1365_2710_2011_01302_x crossref_primary_10_1016_j_ygyno_2016_10_011 crossref_primary_10_1185_03007995_2012_735646 crossref_primary_10_1139_cjpp_2022_0265 crossref_primary_10_1016_S2221_1691_12_60444_4 crossref_primary_10_14341_2072_0351_6048 crossref_primary_10_1007_s12072_013_9451_2 crossref_primary_10_1002_14651858_CD010574 crossref_primary_10_14341_2072_0351_6049 crossref_primary_10_1177_1474651409103867 crossref_primary_10_1007_s00125_010_1992_5 crossref_primary_10_1016_S1888_9891_09_70714_1 crossref_primary_10_3389_fpubh_2023_1164536 crossref_primary_10_1111_j_1464_5491_2010_03133_x crossref_primary_10_1111_j_1745_7599_2012_00720_x crossref_primary_10_1016_j_jdiacomp_2014_03_014 crossref_primary_10_1007_s13300_013_0035_x crossref_primary_10_1016_S1751_9918_10_60003_4 crossref_primary_10_2337_dcS15_3003 crossref_primary_10_1016_j_exer_2021_108763 crossref_primary_10_3390_ijms241814051 crossref_primary_10_1016_j_pan_2012_01_004 crossref_primary_10_2337_dc11_1447 crossref_primary_10_1111_j_1742_1241_2010_02590_x crossref_primary_10_2337_dcS13_2035 crossref_primary_10_1016_S1134_3230_10_63007_4 crossref_primary_10_1111_aor_13353 crossref_primary_10_1158_1940_6207_CAPR_10_0157 crossref_primary_10_4061_2011_749653 crossref_primary_10_5124_jkma_2014_57_5_435 crossref_primary_10_3810_pgm_2013_09_2698 crossref_primary_10_1093_eurheartj_sus001 crossref_primary_10_1080_13813455_2020_1806885 crossref_primary_10_5867_medwave_2012_02_5306 crossref_primary_10_2337_dc13_0356 crossref_primary_10_1021_mp400288e crossref_primary_10_1007_s00125_010_1905_7 crossref_primary_10_1038_ng_735 crossref_primary_10_1186_s13098_021_00632_9 crossref_primary_10_2337_dc11_2301 crossref_primary_10_3390_ph17060736 crossref_primary_10_1111_j_2040_1124_2010_00004_x crossref_primary_10_2174_1573399820666230807145202 crossref_primary_10_4137_CMT_S6227 crossref_primary_10_1016_j_diabet_2013_05_005 crossref_primary_10_1111_1755_5922_12000 crossref_primary_10_1111_j_1463_1326_2010_01294_x crossref_primary_10_2165_11532980_000000000_00000 crossref_primary_10_1016_j_clinthera_2017_02_008 crossref_primary_10_1039_c3mb70196d crossref_primary_10_1016_S0140_6736_14_61037_0 crossref_primary_10_1007_s11428_011_0684_1 crossref_primary_10_1007_s00125_009_1441_5 crossref_primary_10_1007_s00125_013_2872_6 crossref_primary_10_1002_14651858_CD012368_pub2 crossref_primary_10_1016_j_ejim_2011_10_007 crossref_primary_10_1111_andr_12755 crossref_primary_10_1155_2017_5202684 crossref_primary_10_1200_JCO_2011_39_7505 crossref_primary_10_1016_j_orcp_2011_07_002 crossref_primary_10_2217_pme_11_36 crossref_primary_10_2337_dc11_1465 crossref_primary_10_1007_s11255_016_1288_x crossref_primary_10_1155_2015_806979 crossref_primary_10_1016_S1155_1941_12_53865_5 crossref_primary_10_1024_0301_1526_a000737 crossref_primary_10_1089_dia_2014_0157 crossref_primary_10_1111_j_1463_1326_2011_01469_x crossref_primary_10_1002_oby_21852 crossref_primary_10_3390_ph15050626 crossref_primary_10_1016_j_ejmech_2017_02_007 crossref_primary_10_1007_s00125_017_4335_y crossref_primary_10_1007_s00228_011_1013_8 crossref_primary_10_2165_11316510_000000000_00000 crossref_primary_10_2165_11597820_000000000_00000 crossref_primary_10_1097_MD_0000000000006888 crossref_primary_10_1177_1474651410397255 crossref_primary_10_1007_s11695_016_2118_z crossref_primary_10_1016_j_scp_2023_101181 crossref_primary_10_2337_dc11_1638 crossref_primary_10_1007_s00125_011_2311_5 crossref_primary_10_2337_dc12_2454 crossref_primary_10_1016_j_jdiacomp_2018_02_009 crossref_primary_10_1007_s00125_014_3428_0 crossref_primary_10_1186_s12902_021_00892_6 crossref_primary_10_1016_S0140_6736_09_60942_9 crossref_primary_10_1007_s00125_014_3372_z crossref_primary_10_1136_bmjopen_2011_000219 crossref_primary_10_1186_1471_2458_13_678 crossref_primary_10_1002_med_21441 crossref_primary_10_1038_nrendo_2011_30 crossref_primary_10_18632_aging_103358 crossref_primary_10_4093_jkd_2011_12_4_211 crossref_primary_10_1111_1440_1681_12332 crossref_primary_10_4093_dmj_2012_36_4_280 crossref_primary_10_1371_journal_pone_0057222 crossref_primary_10_1155_2014_693074 crossref_primary_10_2337_db14_0302 crossref_primary_10_1097_MOL_0b013e328334096a crossref_primary_10_1007_s11892_013_0374_z crossref_primary_10_1016_j_dsx_2022_102528 crossref_primary_10_1089_lap_2018_0394 crossref_primary_10_1517_14712598_2010_512286 crossref_primary_10_1007_s00296_017_3758_6 crossref_primary_10_14341_probl201359525_31 crossref_primary_10_2217_thy_09_33 crossref_primary_10_1038_nrd2782 crossref_primary_10_1007_s00125_012_2534_0 crossref_primary_10_1111_jgh_13639 crossref_primary_10_1556_OH_2014_29828 crossref_primary_10_1007_s00125_010_1937_z crossref_primary_10_1016_S1134_3230_10_64014_8 crossref_primary_10_1089_dia_2016_0017 crossref_primary_10_1016_S1751_9918_10_60008_3 crossref_primary_10_1016_j_diabres_2011_08_021 crossref_primary_10_1016_j_ejim_2016_05_027 crossref_primary_10_1016_j_diabet_2010_03_009 crossref_primary_10_1016_j_diabet_2010_03_007 crossref_primary_10_1249_MSS_0b013e31827ad8b4 crossref_primary_10_1007_s00125_009_1636_9 crossref_primary_10_1016_S0140_6736_10_60407_2 crossref_primary_10_1186_1758_5996_6_37 crossref_primary_10_2298_YJOR1001099T crossref_primary_10_1097_AOG_0000000000001332 crossref_primary_10_1016_j_clinthera_2010_05_002 crossref_primary_10_1155_2020_5901569 crossref_primary_10_1186_1476_511X_13_87 crossref_primary_10_2337_dc12_2462 crossref_primary_10_1007_s40261_013_0068_y crossref_primary_10_1002_pds_2262 crossref_primary_10_1016_j_pcd_2009_08_004 crossref_primary_10_1517_14656566_2012_642866 crossref_primary_10_1517_14656566_2012_642867 crossref_primary_10_1093_ndt_gft536 crossref_primary_10_1111_j_1755_6686_2012_00283_x crossref_primary_10_1093_humupd_dmu037 crossref_primary_10_1007_s00125_010_1891_9 crossref_primary_10_1111_fcp_12001 crossref_primary_10_3390_nu14193927 crossref_primary_10_1016_j_lfs_2019_116545 crossref_primary_10_1016_S1134_3230_10_64003_3 crossref_primary_10_1016_S2173_5050_09_70031_7 crossref_primary_10_1016_j_diabres_2012_09_001 crossref_primary_10_1016_S0873_2159_15_30070_2 crossref_primary_10_1177_2040622313494986 crossref_primary_10_1038_ki_2011_444 crossref_primary_10_1111_jdi_12457 crossref_primary_10_1177_1474651410388976 crossref_primary_10_1016_S0140_6736_10_60399_6 crossref_primary_10_1111_j_1365_2265_2012_04468_x crossref_primary_10_3748_wjg_v22_i27_6100 crossref_primary_10_1155_2010_178372 crossref_primary_10_3390_cancers12010210 crossref_primary_10_1007_s00108_012_3203_6 crossref_primary_10_1007_s00125_012_2642_x crossref_primary_10_1186_1758_5996_5_43 crossref_primary_10_1007_s11055_018_0657_6 crossref_primary_10_4137_CMT_S1085 crossref_primary_10_1007_s13340_011_0056_5 crossref_primary_10_1111_dom_12067 crossref_primary_10_1056_NEJMe0908706 crossref_primary_10_1007_s00125_015_3595_7 crossref_primary_10_1007_s00580_012_1620_5 crossref_primary_10_1155_2018_2483273 crossref_primary_10_1155_2012_895370 crossref_primary_10_1016_j_ebiom_2023_104674 crossref_primary_10_1177_0897190012465985 crossref_primary_10_3810_pgm_2011_07_2318 crossref_primary_10_1016_j_diabres_2011_09_023 crossref_primary_10_1186_s12913_018_2860_0 crossref_primary_10_1155_2012_981896 crossref_primary_10_1186_s12877_019_1256_2 crossref_primary_10_1586_erc_10_98 crossref_primary_10_1111_dom_14573 crossref_primary_10_1517_14656566_2011_589835 crossref_primary_10_1056_NEJMc091419 crossref_primary_10_1007_s12467_013_0061_3 crossref_primary_10_1016_j_endoen_2012_11_007 crossref_primary_10_1093_humupd_dmw025 crossref_primary_10_1016_S1957_2557_09_71625_6 crossref_primary_10_1185_03007991003738063 crossref_primary_10_1002_14651858_CD012906 crossref_primary_10_1111_1753_0407_12426 crossref_primary_10_4102_phcfm_v4i1_392 crossref_primary_10_1007_s13167_010_0010_9 crossref_primary_10_12968_indn_2009_13_2_76424 crossref_primary_10_1016_S1957_2557_10_70049_3 crossref_primary_10_1007_s00125_017_4364_6 crossref_primary_10_1016_S1134_3230_10_64016_1 crossref_primary_10_4093_dmj_2013_37_2_117 crossref_primary_10_1517_14712598_2014_904851 crossref_primary_10_1016_j_nupar_2011_11_002 crossref_primary_10_1586_17446651_2014_894876 crossref_primary_10_1155_2019_5308308 crossref_primary_10_2133_dmpk_DMPK_12_RG_082 crossref_primary_10_1002_14651858_CD012906_pub2 crossref_primary_10_2478_v10039_012_0078_7 crossref_primary_10_1016_j_ejmech_2013_02_002 crossref_primary_10_1016_S1751_9918_10_60006_X crossref_primary_10_1016_S1134_3230_10_63015_3 crossref_primary_10_1111_j_1474_9726_2010_00642_x crossref_primary_10_3389_fphar_2024_1415740 crossref_primary_10_1016_j_diabres_2012_05_022 crossref_primary_10_3310_hta21020 crossref_primary_10_1111_j_1365_2796_2012_02528_x crossref_primary_10_36106_gjra_6002955 crossref_primary_10_1155_2013_969824 crossref_primary_10_1159_000381163 crossref_primary_10_1517_14728214_2013_831405 crossref_primary_10_2459_JCM_0b013e32835dbd0d crossref_primary_10_3892_ol_2017_7370 crossref_primary_10_14814_phy2_12477 crossref_primary_10_1039_D2LC00468B crossref_primary_10_4103_jod_jod_48_22 crossref_primary_10_1200_JCO_2011_39_3769 crossref_primary_10_2337_dc12_0788 crossref_primary_10_1016_S0140_6736_12_60401_2 crossref_primary_10_1111_j_1463_1326_2012_01628_x crossref_primary_10_1177_1478271520093901020 crossref_primary_10_1089_dia_2013_0363 crossref_primary_10_1186_1472_6823_12_1 crossref_primary_10_1111_j_1365_2605_2010_01117_x crossref_primary_10_2337_dc11_1928 crossref_primary_10_1007_s11695_015_1973_3 crossref_primary_10_1016_S1957_2557_10_70161_9 crossref_primary_10_1016_j_clinthera_2017_09_016 crossref_primary_10_1186_s13059_017_1270_7 crossref_primary_10_1007_s00125_008_1225_3 crossref_primary_10_2337_dc12_0413 crossref_primary_10_1038_s41387_019_0093_x crossref_primary_10_1016_j_diabet_2012_08_002 crossref_primary_10_1056_NEJMe1202443 crossref_primary_10_1111_j_2040_1124_2012_00238_x crossref_primary_10_1007_s00125_010_1702_3 crossref_primary_10_1007_s40200_021_00920_1 crossref_primary_10_7314_APJCP_2015_16_1_221 crossref_primary_10_1016_S0140_6736_11_61027_1 crossref_primary_10_1155_2014_890639 crossref_primary_10_33320_maced_pharm_bull_2022_68_03_238 crossref_primary_10_1007_s00125_008_1236_0 crossref_primary_10_1016_j_ejmech_2014_09_007 crossref_primary_10_1007_s00125_010_1846_1 crossref_primary_10_1111_j_1463_1326_2012_01604_x crossref_primary_10_1016_j_diabres_2019_107946 crossref_primary_10_1038_srep26442 crossref_primary_10_1016_j_pcd_2016_10_001 crossref_primary_10_1186_1477_7525_12_87 crossref_primary_10_3390_diagnostics13081386 crossref_primary_10_2337_dc11_0857 crossref_primary_10_1111_j_1463_1326_2009_01091_x crossref_primary_10_1002_14651858_CD009008_pub3 crossref_primary_10_2337_dc12_2620 crossref_primary_10_1016_j_diabres_2011_03_021 crossref_primary_10_1016_j_diabet_2011_11_001 crossref_primary_10_1530_EJE_11_0022 crossref_primary_10_1155_2012_147256 crossref_primary_10_7243_2050_0866_1_20 crossref_primary_10_1016_j_dsx_2016_01_004 crossref_primary_10_1042_CS20160491 crossref_primary_10_4236_ojemd_2018_82007 crossref_primary_10_1111_j_1463_1326_2011_01372_x crossref_primary_10_2298_SARH0910490K crossref_primary_10_1007_s10238_015_0406_x crossref_primary_10_1007_s13300_011_0005_0 crossref_primary_10_1111_ijcp_13485 crossref_primary_10_3389_fcvm_2022_845307 crossref_primary_10_1177_0003319710366431 crossref_primary_10_3390_ph15101274 crossref_primary_10_1517_17425255_2012_658771 crossref_primary_10_1016_j_clgc_2015_12_012 crossref_primary_10_1111_j_1463_1326_2011_01506_x crossref_primary_10_1016_S0168_8227_09_70005_1 crossref_primary_10_1016_S1957_2557_13_70603_5 crossref_primary_10_1517_13543784_2010_505235 crossref_primary_10_1007_s00125_013_2856_6 crossref_primary_10_1016_S1575_0922_09_71945_X crossref_primary_10_2478_v10255_012_0044_y crossref_primary_10_3390_nano10102005 crossref_primary_10_4158_EP09181_RA crossref_primary_10_1586_eem_10_17 crossref_primary_10_2337_dc14_1984 crossref_primary_10_1111_j_1600_6143_2011_03855_x crossref_primary_10_1007_s00125_012_2537_x crossref_primary_10_1016_j_beem_2009_03_011 crossref_primary_10_1016_j_clinthera_2013_01_010 crossref_primary_10_1016_j_beem_2009_03_010 crossref_primary_10_1515_mr_2024_0039 crossref_primary_10_1124_mol_113_089763 crossref_primary_10_1177_2042098612454290 crossref_primary_10_18294_sc_2017_1341 crossref_primary_10_5662_wjm_v6_i2_133 crossref_primary_10_1111_cen_12119 crossref_primary_10_3390_biom11010125 crossref_primary_10_1016_j_jhep_2015_02_008 crossref_primary_10_1371_journal_pone_0132118 crossref_primary_10_1016_j_jdiacomp_2016_03_027 crossref_primary_10_1007_s00125_009_1491_8 crossref_primary_10_1007_s00592_012_0374_5 crossref_primary_10_1016_S1957_2557_12_70660_0 crossref_primary_10_1109_ACCESS_2017_2707384 crossref_primary_10_1507_endocrj_EJ11_0378 crossref_primary_10_1093_ndt_gfq199 crossref_primary_10_1016_S0140_6736_09_60198_7 crossref_primary_10_2337_dc14_0779 crossref_primary_10_1007_s00125_011_2435_7 crossref_primary_10_1007_s00125_012_2646_6 crossref_primary_10_1592_phco_31_12_44S crossref_primary_10_1007_s00125_009_1512_7 crossref_primary_10_1038_s41387_019_0072_2 crossref_primary_10_1155_2014_294017 crossref_primary_10_1186_s40169_017_0162_5 crossref_primary_10_2337_dc09_9031 crossref_primary_10_2337_dc09_9030 crossref_primary_10_2337_dc09_9033 crossref_primary_10_1185_03007995_2011_555755 crossref_primary_10_2337_dc10_1263 crossref_primary_10_1007_s00125_012_2635_9 crossref_primary_10_1111_j_1463_1326_2012_01613_x crossref_primary_10_2217_pgs_13_17 crossref_primary_10_1002_pds_2345 crossref_primary_10_4137_CMED_S5976 crossref_primary_10_1016_S0140_6736_10_60746_5 crossref_primary_10_2337_diaspect_25_3_154 |
| Cites_doi | 10.1056/NEJMoa0802987 10.1056/NEJMoa012512 10.1097/00000658-199509000-00011 10.2337/diacare.25.8.1410 10.1007/s00125-006-0416-z 10.1056/NEJMcp021106 10.1001/jama.1989.03420080075034 10.1001/jama.298.2.194 10.2337/dc06-1789 10.1056/NEJMoa0802743 10.1001/jama.289.19.2560 10.2337/dc07-0141 10.1016/0168-8227(95)01064-K 10.1056/NEJM199508313330902 10.1016/S0140-6736(98)07037-8 10.7326/0003-4819-147-6-200709180-00178 10.1002/14651858.CD003639.pub2 10.7326/0003-4819-108-3-334 10.1136/bmj.39247.447431.BE 10.7326/0003-4819-130-5-199903020-00002 10.1056/NEJMoa022314 10.1016/j.diabres.2007.08.024 10.1001/archinte.161.13.1653 10.1016/S0140-6736(08)60762-X 10.1111/j.1464-5491.2007.02221.x 10.2337/diacare.22.5.789 10.2337/diacare.27.11.2628 10.1056/NEJMoa052187 10.1136/bmj.321.7258.405 10.2337/diacare.28.12.2948 10.2337/diacare.20.9.1353 10.2337/diacare.26.8.2238 10.2337/diacare.14.7.639 10.2337/dc08-S012 10.1001/archinte.168.8.820 10.2337/diacare.28.7.1547 10.2337/diacare.27.6.1265 10.1001/jama.298.10.1189 10.2337/diacare.28.6.1510 10.2337/diacare.28.9.2093 10.2337/diacare.28.4.888 10.3121/cmr.1.3.189 10.2337/diacare.25.4.708 10.2337/diacare.15.6.737 10.2337/diacare.27.10.2363 10.7326/0003-4819-143-8-200510180-00006 10.1056/NEJMra041001 10.1056/NEJMoa035622 10.1016/S0140-6736(98)07019-6 10.2337/diab.44.8.968 10.1056/NEJMoa066224 10.2337/dc07-0589 10.1056/NEJMoa073394 10.2337/diab.44.11.1249 10.1001/jama.290.4.486 10.1001/jama.298.10.1180 10.2337/dc07-0627 10.1056/NEJM199307293290502 10.1002/dmrr.235 10.2337/diaclin.23.2.78 10.2337/diacare.28.5.1083 10.1136/bmj.3.5978.276 10.2165/00024677-200302060-00004 10.2337/diacare.13.12.1240 10.1056/NEJMoa072761 10.1161/01.CIR.0000133317.49796.0E 10.1038/ncpendmet0017 10.1001/jama.287.3.360 10.1002/14651858.CD006739.pub2 10.1007/s00125-007-0873-z 10.2337/diacare.28.11.2703 10.1056/NEJM199602293340906 10.2337/diacare.18.8.1113 10.2337/diacare.28.5.1092 10.1001/jama.1988.03410190112033 10.1016/S0140-6736(05)67528-9 10.2337/diacare.28.2.260 10.1046/j.1464-5491.1999.00166.x 10.2337/diabetes.53.suppl_3.S233 10.1056/NEJMp068294 10.1111/j.1463-1326.2008.00933.x 10.2337/dc07-0048 |
| ContentType | Journal Article |
| Copyright | Springer-Verlag 2008 2009 INIST-CNRS Springer-Verlag 2009 |
| Copyright_xml | – notice: Springer-Verlag 2008 – notice: 2009 INIST-CNRS – notice: Springer-Verlag 2009 |
| CorporateAuthor | American Diabetes Association European Association for the Study of Diabetes |
| CorporateAuthor_xml | – name: European Association for the Study of Diabetes – name: American Diabetes Association |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1007/s00125-008-1157-y |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1432-0428 |
| EndPage | 30 |
| ExternalDocumentID | 1606648531 18941734 21091994 10_1007_s00125_008_1157_y |
| Genre | Consensus Development Conference Research Support, Non-U.S. Gov't Journal Article Conference News |
| GeographicLocations | United States Europe |
| GeographicLocations_xml | – name: Europe – name: United States |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1CY 1N0 1SB 2.D 203 28- 29F 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X A8Z AAAVM AABHQ AACDK AAEWM AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFFNX AFJLC AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z J5H JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- MVM N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P6G P9S PF0 PQQKQ PROAC PSQYO PT4 Q2X QOK QOR QOS R4E R89 R9I RHV RIG ROL RPX RRX RSV S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TR2 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK8 X7M YLTOR Z45 Z7U Z7V Z7W Z82 Z83 Z87 Z8O Z8P Z8Q Z8V Z8W Z91 Z92 ZGI ZMTXR ZOVNA ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION ESTFP PHGZM PHGZT PJZUB PPXIY PUEGO IQODW CGR CUY CVF ECM EIF NPM 7T5 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-c329t-2a025402e87da7337d2e68e36d0a1ac7cfcc48859dd97ed359b2210e6b9c06f3 |
| IEDL.DBID | U2A |
| ISSN | 0012-186X 1432-0428 |
| IngestDate | Mon Sep 08 10:36:41 EDT 2025 Tue Oct 07 05:35:47 EDT 2025 Wed Feb 19 01:47:05 EST 2025 Mon Jul 21 09:14:24 EDT 2025 Thu Apr 24 22:51:55 EDT 2025 Wed Oct 01 02:46:24 EDT 2025 Fri Feb 21 02:35:19 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | HbA1c Level Glycaemic Control Lifestyle Intervention Consensus Algorithm Metformin Endocrinopathy Type 2 diabetes Metabolic diseases Hyperglycemia Association |
| Language | English |
| License | http://www.springer.com/tdm CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c329t-2a025402e87da7337d2e68e36d0a1ac7cfcc48859dd97ed359b2210e6b9c06f3 |
| Notes | SourceType-Scholarly Journals-1 ObjectType-News-1 content type line 14 ObjectType-Conference-2 ObjectType-Feature-4 content type line 23 ObjectType-Article-3 |
| PMID | 18941734 |
| PQID | 213845564 |
| PQPubID | 48469 |
| PageCount | 14 |
| ParticipantIDs | proquest_miscellaneous_66732838 proquest_journals_213845564 pubmed_primary_18941734 pascalfrancis_primary_21091994 crossref_citationtrail_10_1007_s00125_008_1157_y crossref_primary_10_1007_s00125_008_1157_y springer_journals_10_1007_s00125_008_1157_y |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20090100 2009-1-00 2009 2009-Jan 20090101 |
| PublicationDateYYYYMMDD | 2009-01-01 |
| PublicationDate_xml | – month: 1 year: 2009 text: 20090100 |
| PublicationDecade | 2000 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Heidelberg – name: Germany |
| PublicationSubtitle | Clinical and Experimental Diabetes and Metabolism |
| PublicationTitle | Diabetologia |
| PublicationTitleAbbrev | Diabetologia |
| PublicationTitleAlternate | Diabetologia |
| PublicationYear | 2009 |
| Publisher | Springer-Verlag Springer Springer Nature B.V |
| Publisher_xml | – name: Springer-Verlag – name: Springer – name: Springer Nature B.V |
| References | The ADVANCE Collaborative GroupIntensive blood glucose control and vascular outcomes in patients with type 2 diabetesN Engl J Med20083582560257210.1056/NEJMoa0802987 RiddleMFriasJZhangBPramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulinDiabetes Care200730279427991769861510.2337/dc07-05891:CAS:528:DC%2BD2sXhtlKhs7rE DruckerDJBiologic actions and therapeutic potential of the proglucagon-derived peptidesNature Endocrinol Metab20051223110.1038/ncpendmet00171:CAS:528:DC%2BD28Xis1Sisb0%3D MeinertCLKnatterudGLProutTEKlimtCRThe University Group Diabetes Program: a study of the effect of hypoglycemic agents on vascular complications in patients with adult-onset diabetesII Mortality results. Diabetes197019Suppl 1789830 ChiassonJLJosseRGGomisRHanefeldMKarasikALaaksoMAcarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM TrialJAMA20032904864941287609110.1001/jama.290.4.4861:CAS:528:DC%2BD3sXls1yjs7c%3D European Diabetes Policy GroupA desk-top guide to type 2 diabetes mellitusDiabet Med19991671673010.1046/j.1464-5491.1999.00166.x American Diabetes Association. Standards of medical care in diabetesDiabetes Care200831Suppl 1S12S54 SheehanMTCurrent therapeutic options in type 2 diabetes mellitus: a practical approachClin Med Res200311892001593130910.3121/cmr.1.3.189 Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch C (2008) Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2:CD006739 Diabetes Prevention Program Research GroupImpact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention ProgramDiabetes Care20052888889410.2337/diacare.28.4.888 UK Prospective Diabetes Study (UKPDS) GroupEffect of intensive blood glucose control with metformin on complication in overweight patients with type 2 diabetes (UKPDS 34)Lancet199835285486510.1016/S0140-6736(98)07037-8 GroopLSulfonylureas in NIDDMDiabetes Care199215737747160083410.2337/diacare.15.6.7371:STN:280:DyaK383ovFCitg%3D%3D MeierCKraenzlinMEBodmerMJickSSJickHMeierCRUse of thiazolidinediones and fracture riskArch Intern Med20081688208251844325610.1001/archinte.168.8.8201:CAS:528:DC%2BD1cXmtFSrsLg%3D OhkuboYKishikawaHArakiEIntensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with NIDDM: A randomized prospective 6-year studyDiab Res Clin Pract19952810311710.1016/0168-8227(95)01064-K1:CAS:528:DyaK2MXpsVWgtrs%3D Abraira C, Duckworth WC, Moritz T (2008) Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report. Diabetes Obes Metab. doi:10.1111/j.1463-1326.2008.00933.x GoldbergRBKendallDMDeegMAGLAI Study InvestigatorsA comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemiaDiabetes Care200528154715541598329910.2337/diacare.28.7.15471:CAS:528:DC%2BD2MXms12ntLk%3D ChaseHPJacksonWEHoopsSLCockerhamRSArcherPGO’BrienDGlucose control and the renal and retinal complications of insulin-dependent diabetesJAMA1989261115560291543710.1001/jama.261.8.11551:STN:280:DyaL1M7isFygsg%3D%3D BuseJBHenryRRHanJKimDDFinemanMSBaronADExenatide-113 Clinical Study Group. Effects of exenatide on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetesDiabetes Care20052726283510.2337/diacare.27.11.2628 Yki-JarvinenHDrug therapy: thiazolidinedionesN Engl J Med200435111061535630810.1056/NEJMra041001 NathanDMFinding new treatments for diabetes—how many, how fast … how good?N Engl J Med20073564374401726790110.1056/NEJMp0682941:CAS:528:DC%2BD2sXht1ekurg%3D ReichardPNilssonB-YRosenqvistUThe effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitusN Engl J Med1993329304309814796010.1056/NEJM1993072932905021:STN:280:DyaK3szgvFGisg%3D%3D BaileyCJTurnerRCMetforminN Engl J Med1996334574583856982610.1056/NEJM1996022933409061:CAS:528:DyaK28XhvVCjs74%3D PetersALDavidsonMBMaximal dose glyburide in markedly symptomatic patients with type 2 diabetes: a new use for an old friendJ Clin Endocrinol Metab1996812423867555510.1210/jc.81.7.24231:CAS:528:DyaK28XktFaks70%3D Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research GroupIntensive diabetes therapy and carotid intima–media thickness in type 1 diabetesN Engl J Med20033482294230310.1056/NEJMoa022314 Diabetes Control and Complications Trial Research GroupThe effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications TrialN Engl J Med1993329978986 RewersMHammanRFHarrisMRisk factors for non-insulin dependent diabetesDiabetes in America, 2nd ed. NIH Publication No. 95–14681995BethesdaNational Institutes of Health179220 KahnSEHaffnerSMHeiseMAADOPT Study GroupGlycemic durability of rosiglitazone, metformin, or glyburide monotherapyN Engl J Med2006355242724431714574210.1056/NEJMoa0662241:CAS:528:DC%2BD28Xht12ntrzF GenuthSInsulin use in NIDDMDiabetes Care199013124064227630910.2337/diacare.13.12.12401:STN:280:DyaK3M7hsVCqtA%3D%3D Diabetes Prevention Program Research GroupReduction in incidence of type 2 diabetes with lifestyle intervention or metforminN Engl J Med200234639340310.1056/NEJMoa012512 KleinRKleinBEKMossSEDavisMDDeMetsDLGlycosylated hemoglobin predicts the incidence and progression of diabetic retinopathyJAMA198826028642871318435110.1001/jama.260.19.28641:STN:280:DyaL1M%2FjslGjug%3D%3D MillerCDPhillipsLSZiemerDCGallinaDLCookCBEl-KebbiIMHypoglycemia in patients with type 2 diabetes mellitusArch Int Med20051611653165910.1001/archinte.161.13.1653 ZammittNNFrierBMHypoglycemia in type 2 diabetesDiabetes Care200528294829611630656110.2337/diacare.28.12.2948 NathanDMBuseJBDavidsonMBManagement of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapyUpdate regarding the thiazolidinediones. Diabetologia2008518111:STN:280:DC%2BD2sjgvFGktA%3D%3D DCCT Research GroupThe association between glycemic exposure and long-term diabetic complications in the Diabetes Control and Complications TrialDiabetes19954496898310.2337/diabetes.44.8.968 WengJLiYXuWEffect of intensive insulin therapy on beta-cell function and glycemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomized parallel-group trialLancet2008371175317601850229910.1016/S0140-6736(08)60762-X1:CAS:528:DC%2BD1cXmt1Ontr4%3D SinghSLokeYKFurbergCDLong-term risk of cardiovascular events with rosiglitazone: a meta-analysisJAMA2007298118911951784865310.1001/jama.298.10.11891:CAS:528:DC%2BD2sXhtVGmtL3K DixonJBO’BrienPEPlayfairJAdjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trialJAMA20082993163231821231610.1001/jama.299.3.3161:CAS:528:DC%2BD1cXhtFertLs%3D DeFronzoRGoodmanAEfficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study GroupN Engl J Med1995333541549762390210.1056/NEJM1995083133309021:CAS:528:DyaK2MXpsVanurY%3D HomePDPocockSJBeck-NielsenHRECORD Study GroupRosiglitazone evaluated for cardiovascular outcomes—an interim analysisN Engl J Med200735728381755115910.1056/NEJMoa0733941:CAS:528:DC%2BD2sXnsVCqs7w%3D Van de Laar FA, Lucassen PL, Akkermans RP et al (2005) Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2:CD003639 RosenstockJHassmanDRMadderRDRepaglinide versus nateglinide monotherapy: a randomized, multicenter studyDiabetes Care200427126512701516177310.2337/diacare.27.6.12651:CAS:528:DC%2BD2cXlt1yltb0%3D HirschIBBergenstalRMParkinCGWrightEBuseJBA real-world approach to insulin therapy in primary care practiceClinical Diabetes200523788610.2337/diaclin.23.2.78 ShawJSWilmotRLKilpatrickESEstablishing pragmatic estimated GFR thresholds to guide metformin prescribingDiabetic Medicine200724116011631767286010.1111/j.1464-5491.2007.02221.x1:STN:280:DC%2BD2srmslSksQ%3D%3D GangjiASCukiermanTGersteinHCGoldsmithCHClaseCMA systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulinDiabetes Care200730389941725951810.2337/dc06-1789 LincoffAMWolskiKNichollsSJNissenSEPioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trialsJAMA2007298118011881784865210.1001/jama.298.10.11801:CAS:528:DC%2BD2sXhtVGmtL3J RazIHanefeldMXuLCariaCDaviesMWilliams-HermanDSitagliptin Study 023 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitusDiabetologia200649256425711700147110.1007/s00125-006-0416-z1:CAS:528:DC%2BD28XhtFOqsrvF NathanDMInitial management of glycemia in type 2 diabetes mellitusN Engl J Med2002347134213491239719310.1056/NEJMcp021106 StrattonIMAdlerAINeilHAAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ20003214054121093804810.1136/bmj.321.7258.4051:STN:280:DC%2BD3cvisFWnsg%3D%3D MonamiMLamannacCMarchionniNMannucciEComparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysisDiabetes Res Clin Pract2008791962031793173310.1016/j.diabres.2007.08.0241:CAS:528:DC%2BD1cXhsVKisbk%3D ChobanianAVBakrisGLBlackHRNational Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment Of High Blood Pressure; National High blood Pressure Education Program Coordinating committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment Of High Blood Pressure: the JNC 7 reportJAMA2003289256025721274819910.1001/jama.289.19.25601:CAS:528:DC%2BD3sXjvFCqtrk%3D InzucchiSEOral antihyperglycemic therapy WJ Malaisse (1157_CR28) 2003; 2 S Colagiuri (1157_CR38) 2002; 25 DCCT Research Group (1157_CR23) 1995; 44 P Raskin (1157_CR72) 2005; 28 S Singh (1157_CR66) 2007; 298 S Schwartz (1157_CR91) 2003; 26 The ADVANCE Collaborative Group (1157_CR12) 2008; 358 HP Chase (1157_CR19) 1989; 261 Diabetes Prevention Program Research Group (1157_CR46) 2005; 28 A Farmer (1157_CR86) 2007; 335 UKPDS Group (1157_CR89) 1995; 44 P Damsbo (1157_CR59) 1999; 22 S Salpeter (1157_CR51) 2006; 1 H Yki-Jarvinen (1157_CR31) 2004; 351 WJ Pories (1157_CR42) 1995; 222 DM Kendall (1157_CR78) 2005; 28 A Holstein (1157_CR53) 2001; 17 JA Dormandy (1157_CR67) 2005; 366 K Horvath (1157_CR71) 2007; 2 JS Shaw (1157_CR52) 2007; 24 S Genuth (1157_CR30) 1990; 13 CD Miller (1157_CR77) 2005; 161 RB Goldberg (1157_CR64) 2005; 28 IB Hirsch (1157_CR90) 2005; 23 R DeFronzo (1157_CR49) 1995; 333 LMC Welschen (1157_CR85) 2005; 28 DJ Drucker (1157_CR32) 2005; 1 DR Hadden (1157_CR47) 1975; 3 AE Pontiroli (1157_CR45) 2005; 28 MA Khan (1157_CR63) 2002; 25 DM Nathan (1157_CR15) 2002; 347 UK Prospective Diabetes Study (UKPDS) Group (1157_CR6) 1998; 352 G Dailey (1157_CR73) 2004; 27 J Gerich (1157_CR58) 2005; 28 SE Kahn (1157_CR55) 2006; 355 J Weng (1157_CR88) 2008; 371 CL Meinert (1157_CR56) 1970; 19 SE Inzucchi (1157_CR17) 2002; 287 AV Chobanian (1157_CR22) 2003; 289 AL Peters (1157_CR48) 1996; 81 RA DeFronzo (1157_CR79) 2005; 28 H Ilkova (1157_CR87) 1997; 20 I Raz (1157_CR83) 2006; 49 UK Prospective Diabetes Study (UKPDS) Group (1157_CR7) 1998; 352 H Yki-Jarvinen (1157_CR92) 1999; 130 Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (1157_CR9) 2003; 348 1157_CR13 RE Amori (1157_CR35) 2007; 298 CJ Bailey (1157_CR27) 1996; 334 Look AHEAD Research Group (1157_CR41) 2007; 30 B Goldstein (1157_CR84) 2007; 30 1157_CR29 JL Chiasson (1157_CR60) 2003; 290 M Riddle (1157_CR82) 2007; 30 Y Ohkubo (1157_CR8) 1995; 28 The Action to Control Cardiovascular Risk in Diabetes Study Group (1157_CR11) 2008; 358 SM Grundy (1157_CR21) 2004; 110 JB Dixon (1157_CR44) 2008; 299 AM Lincoff (1157_CR68) 2007; 298 RR Little (1157_CR20) 2001; 47 M Monami (1157_CR36) 2008; 79 MI Harris (1157_CR39) 1991; 14 Diabetes Prevention Program Research Group (1157_CR50) 2002; 346 L Groop (1157_CR26) 1992; 15 DM Nathan (1157_CR69) 2008; 51 J Rosenstock (1157_CR57) 2004; 27 RJ Heine (1157_CR81) 2005; 143 AS Gangji (1157_CR54) 2007; 30 C Meier (1157_CR70) 2008; 168 S Singh (1157_CR62) 2007; 30 M Rewers (1157_CR40) 1995 1157_CR25 Diabetes Control and Complications Trial Research Group (1157_CR4) 1993; 329 C Abraira (1157_CR75) 1995; 18 JB Buse (1157_CR80) 2005; 27 P Reichard (1157_CR5) 1993; 329 R Klein (1157_CR18) 1988; 260 1157_CR3 PD Home (1157_CR61) 2007; 357 1157_CR1 European Diabetes Policy Group (1157_CR2) 1999; 16 SE Nissen (1157_CR65) 2007; 356 O Schmitz (1157_CR33) 2004; 53 S Bolen (1157_CR37) 2007; 147 L Sjostrom (1157_CR43) 2004; 351 IM Stratton (1157_CR24) 2000; 321 DM Nathan (1157_CR74) 1988; 108 Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (1157_CR10) 2005; 353 DM Nathan (1157_CR14) 2007; 356 MT Sheehan (1157_CR16) 2003; 1 1157_CR34 NN Zammitt (1157_CR76) 2005; 28 15983299 - Diabetes Care. 2005 Jul;28(7):1547-54 12145243 - Diabetes Care. 2002 Aug;25(8):1410-7 15846673 - Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003639 17485570 - Diabetes Care. 2007 Aug;30(8):1979-87 17698615 - Diabetes Care. 2007 Nov;30(11):2794-9 8147960 - N Engl J Med. 1993 Jul 29;329(5):304-9 16371630 - N Engl J Med. 2005 Dec 22;353(25):2643-53 7623902 - N Engl J Med. 1995 Aug 31;333(9):541-9 17551159 - N Engl J Med. 2007 Jul 5;357(1):28-38 17363746 - Diabetes Care. 2007 Jun;30(6):1374-83 12882842 - Diabetes Care. 2003 Aug;26(8):2238-43 17848652 - JAMA. 2007 Sep 12;298(10):1180-8 11919129 - Diabetes Care. 2002 Apr;25(4):708-11 17443605 - Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005613 20803189 - Diabetologia. 2010 Nov;53(11):2285-8 12748199 - JAMA. 2003 May 21;289(19):2560-72 1600834 - Diabetes Care. 1992 Jun;15(6):737-54 18026926 - Diabetologia. 2008 Jan;51(1):8-11 1914813 - Diabetes Care. 1991 Jul;14(7):639-48 18539917 - N Engl J Med. 2008 Jun 12;358(24):2545-59 17931733 - Diabetes Res Clin Pract. 2008 Feb;79(2):196-203 17517853 - N Engl J Med. 2007 Jun 14;356(24):2457-71 15249516 - Circulation. 2004 Jul 13;110(2):227-39 9283777 - Diabetes Care. 1997 Sep;20(9):1353-6 2915437 - JAMA. 1989 Feb 24;261(8):1155-60 7587918 - Diabetes Res Clin Pract. 1995 May;28(2):103-17 16230722 - Ann Intern Med. 2005 Oct 18;143(8):559-69 8569826 - N Engl J Med. 1996 Feb 29;334(9):574-9 17536074 - Diabetes Care. 2007 Aug;30(8):2148-53 18671796 - Diabetes Obes Metab. 2009 Feb;11(2):150-6 16214598 - Lancet. 2005 Oct 8;366(9493):1279-89 18539916 - N Engl J Med. 2008 Jun 12;358(24):2560-72 19107458 - Diabetologia. 2009 Mar;52(3):552-3; author reply 554-5 15931309 - Clin Med Res. 2003 Jul;1(3):189-200 7677463 - Ann Surg. 1995 Sep;222(3):339-50; discussion 350-2 12876091 - JAMA. 2003 Jul 23;290(4):486-94 15616203 - N Engl J Med. 2004 Dec 23;351(26):2683-93 16929363 - Nat Clin Pract Endocrinol Metab. 2005 Nov;1(1):22-31 12788993 - N Engl J Med. 2003 Jun 5;348(23 ):2294-303 15981944 - Treat Endocrinol. 2003;2(6):401-14 10938048 - BMJ. 2000 Aug 12;321(7258):405-12 7589820 - Diabetes. 1995 Nov;44(11):1249-58 17622601 - JAMA. 2007 Jul 11;298(2):194-206 15677776 - Diabetes Care. 2005 Feb;28(2):260-5 17259518 - Diabetes Care. 2007 Feb;30(2):389-94 17672860 - Diabet Med. 2007 Oct;24(10):1160-3 7622004 - Diabetes. 1995 Aug;44(8):968-83 2276309 - Diabetes Care. 1990 Dec;13(12):1240-64 10332683 - Diabetes Care. 1999 May;22(5):789-94 15561917 - Diabetes. 2004 Dec;53 Suppl 3:S233-8 15161773 - Diabetes Care. 2004 Jun;27(6):1265-70 15504997 - Diabetes Care. 2004 Nov;27(11):2628-35 16123472 - Diabetes Care. 2005 Sep;28(9):2093-9 16249543 - Diabetes Care. 2005 Nov;28(11):2703-9 19034415 - Diabetologia. 2009 Mar;52(3):550-1; author reply 554-5 15451901 - Diabetes Care. 2004 Oct;27(10):2363-8 17267901 - N Engl J Med. 2007 Feb 1;356(5):437-40 19259643 - Diabetologia. 2009 May;52(5):986-7 11790216 - JAMA. 2002 Jan 16;287(3):360-72 3184351 - JAMA. 1988 Nov 18;260(19):2864-71 15356308 - N Engl J Med. 2004 Sep 9;351(11):1106-18 17591623 - BMJ. 2007 Jul 21;335(7611):132 11832527 - N Engl J Med. 2002 Feb 7;346(6):393-403 11434798 - Arch Intern Med. 2001 Jul 9;161(13):1653-9 9813653 - Obes Res. 1998 Sep;6 Suppl 2:51S-209S 15855571 - Diabetes Care. 2005 May;28(5):1083-91 9742976 - Lancet. 1998 Sep 12;352(9131):837-53 16306561 - Diabetes Care. 2005 Dec;28(12):2948-61 18502299 - Lancet. 2008 May 24;371(9626):1753-60 7587846 - Diabetes Care. 1995 Aug;18(8):1113-23 10510947 - Diabet Med. 1999 Sep;16(9):716-30 17145742 - N Engl J Med. 2006 Dec 7;355(23):2427-43 1148773 - Br Med J. 1975 Aug 2;3(5978):276-8 16437448 - Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002967 18212316 - JAMA. 2008 Jan 23;299(3):316-23 17848653 - JAMA. 2007 Sep 12;298(10):1189-95 17001471 - Diabetologia. 2006 Nov;49(11):2564-71 15920083 - Diabetes Care. 2005 Jun;28(6):1510-7 4926376 - Diabetes. 1970;19:Suppl:789-830 18443256 - Arch Intern Med. 2008 Apr 28;168(8):820-5 17638715 - Ann Intern Med. 2007 Sep 18;147(6):386-99 18425967 - Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006739 19513689 - Diabetologia. 2009 Aug;52(8):1696-7 15793191 - Diabetes Care. 2005 Apr;28(4):888-94 8366922 - N Engl J Med. 1993 Sep 30;329(14 ):977-86 15855572 - Diabetes Care. 2005 May;28(5):1092-100 11673367 - Clin Chem. 2001 Nov;47(11):1985-92 12397193 - N Engl J Med. 2002 Oct 24;347(17):1342-9 11757083 - Diabetes Metab Res Rev. 2001 Nov-Dec;17(6):467-73 8675555 - J Clin Endocrinol Metab. 1996 Jul;81(7):2423-7 10068412 - Ann Intern Med. 1999 Mar 2;130(5):389-96 3124685 - Ann Intern Med. 1988 Mar;108(3):334-40 18165335 - Diabetes Care. 2008 Jan;31 Suppl 1:S12-54 9742977 - Lancet. 1998 Sep 12;352(9131):854-65 |
| References_xml | – reference: GenuthSInsulin use in NIDDMDiabetes Care199013124064227630910.2337/diacare.13.12.12401:STN:280:DyaK3M7hsVCqtA%3D%3D – reference: SchwartzSSieversRStrangePLynessWHHollanderPInsulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugsDiabetes Care200326223822431288284210.2337/diacare.26.8.22381:CAS:528:DC%2BD3sXmslOktb0%3D – reference: NathanDMInitial management of glycemia in type 2 diabetes mellitusN Engl J Med2002347134213491239719310.1056/NEJMcp021106 – reference: NathanDMFinding new treatments for diabetes—how many, how fast … how good?N Engl J Med20073564374401726790110.1056/NEJMp0682941:CAS:528:DC%2BD2sXht1ekurg%3D – reference: Diabetes Prevention Program Research GroupReduction in incidence of type 2 diabetes with lifestyle intervention or metforminN Engl J Med200234639340310.1056/NEJMoa012512 – reference: DormandyJACharbonnelBEcklandDJASecondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive (PROspective pioglitAzone Clinical Trial in macrovascular Events): a randomized controlled trialLancet2005366127912891621459810.1016/S0140-6736(05)67528-91:CAS:528:DC%2BD2MXhtVOlu7fO – reference: LittleRRRohlfingCLWiedmeyerH-MMyersGLSacksDBGoldsteinDEThe National Glycohemoglobin Standardization Program (NGSP): a five year progress reportClin Chem20014719851992116733671:CAS:528:DC%2BD3MXnvF2jurw%3D – reference: National Institutes of Health (1999) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The Evidence Report. National Heart, Lung, and Blood Institute, NIH, Bethesda, MD – reference: DeFronzoRGoodmanAEfficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study GroupN Engl J Med1995333541549762390210.1056/NEJM1995083133309021:CAS:528:DyaK2MXpsVanurY%3D – reference: Look AHEAD Research GroupReduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trialDiabetes Care2007301374138310.2337/dc07-0048 – reference: AbrairaCJohnsonNColwellJVA CSDM GroupVA Cooperative study on glycemic control and complications in type II diabetesDiabetes Care19951811131123758784610.2337/diacare.18.8.11131:STN:280:DyaK28%2Fgt1Omsw%3D%3D – reference: PoriesWJSwansonMSMacDonaldKGWho would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitusAnn Surg1995222339350767746310.1097/00000658-199509000-000111:STN:280:DyaK2Mvgsl2ltA%3D%3D – reference: InzucchiSEOral antihyperglycemic therapy for type 2 diabetesJAMA2002287360721179021610.1001/jama.287.3.3601:CAS:528:DC%2BD38XksVClsA%3D%3D – reference: IlkovaHGlaserBTunckaleABagriacikNCerasiEInduction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatmentDiabetes Care19972013531356928377710.2337/diacare.20.9.13531:STN:280:DyaK2svivFChtQ%3D%3D – reference: NathanDMRoussellAGodineJEGlyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus: a randomized double-blind studyAnn Int Med198810833434031246851:STN:280:DyaL1c7jt1Wmug%3D%3D – reference: ColagiuriSCullCAHolmanRRUKPDS GroupAre lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? UK Prospective Diabetes Study 61Diabetes Care200225141014171214524310.2337/diacare.25.8.1410 – reference: BolenSFeldmanLVassyJSystematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitusAnn Intern Med200714738639917638715 – reference: DixonJBO’BrienPEPlayfairJAdjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trialJAMA20082993163231821231610.1001/jama.299.3.3161:CAS:528:DC%2BD1cXhtFertLs%3D – reference: DeFronzoRARatnerREHanJEffects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetesDiabetes Care200528109211001585557210.2337/diacare.28.5.10921:CAS:528:DC%2BD2MXksF2hu7g%3D – reference: GoldbergRBKendallDMDeegMAGLAI Study InvestigatorsA comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemiaDiabetes Care200528154715541598329910.2337/diacare.28.7.15471:CAS:528:DC%2BD2MXms12ntLk%3D – reference: LincoffAMWolskiKNichollsSJNissenSEPioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trialsJAMA2007298118011881784865210.1001/jama.298.10.11801:CAS:528:DC%2BD2sXhtVGmtL3J – reference: RosenstockJHassmanDRMadderRDRepaglinide versus nateglinide monotherapy: a randomized, multicenter studyDiabetes Care200427126512701516177310.2337/diacare.27.6.12651:CAS:528:DC%2BD2cXlt1yltb0%3D – reference: RazIHanefeldMXuLCariaCDaviesMWilliams-HermanDSitagliptin Study 023 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitusDiabetologia200649256425711700147110.1007/s00125-006-0416-z1:CAS:528:DC%2BD28XhtFOqsrvF – reference: Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch C (2008) Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2:CD006739 – reference: PontiroliAEFolliFPaganelliMLaparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case–controlled study.Diabetes Care200528270327091624954310.2337/diacare.28.11.2703 – reference: HorvathKJeitlerKBergholdALong-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitusCochrane Database Syst Rev20072CD00561317443605 – reference: HaddenDRMontgomeryDADSkellyRJMaturity onset diabetes mellitus: response to intensive dietary managementBMJ1975327627811487731:STN:280:DyaE2M3gs1Ohtg%3D%3D – reference: KleinRKleinBEKMossSEDavisMDDeMetsDLGlycosylated hemoglobin predicts the incidence and progression of diabetic retinopathyJAMA198826028642871318435110.1001/jama.260.19.28641:STN:280:DyaL1M%2FjslGjug%3D%3D – reference: DCCT Research GroupThe association between glycemic exposure and long-term diabetic complications in the Diabetes Control and Complications TrialDiabetes19954496898310.2337/diabetes.44.8.968 – reference: MillerCDPhillipsLSZiemerDCGallinaDLCookCBEl-KebbiIMHypoglycemia in patients with type 2 diabetes mellitusArch Int Med20051611653165910.1001/archinte.161.13.1653 – reference: Diabetes Control and Complications Trial Research GroupThe effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications TrialN Engl J Med1993329978986 – reference: ReichardPNilssonB-YRosenqvistUThe effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitusN Engl J Med1993329304309814796010.1056/NEJM1993072932905021:STN:280:DyaK3szgvFGisg%3D%3D – reference: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research GroupIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesN Eng J Med20053532643265310.1056/NEJMoa052187 – reference: NissenSEWolskiKEffect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causesN Engl J Med2007356245724711751785310.1056/NEJMoa0727611:CAS:528:DC%2BD2sXms1SisrY%3D – reference: BaileyCJTurnerRCMetforminN Engl J Med1996334574583856982610.1056/NEJM1996022933409061:CAS:528:DyaK28XhvVCjs74%3D – reference: The ADVANCE Collaborative GroupIntensive blood glucose control and vascular outcomes in patients with type 2 diabetesN Engl J Med20083582560257210.1056/NEJMoa0802987 – reference: HirschIBBergenstalRMParkinCGWrightEBuseJBA real-world approach to insulin therapy in primary care practiceClinical Diabetes200523788610.2337/diaclin.23.2.78 – reference: ChobanianAVBakrisGLBlackHRNational Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment Of High Blood Pressure; National High blood Pressure Education Program Coordinating committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment Of High Blood Pressure: the JNC 7 reportJAMA2003289256025721274819910.1001/jama.289.19.25601:CAS:528:DC%2BD3sXjvFCqtrk%3D – reference: PetersALDavidsonMBMaximal dose glyburide in markedly symptomatic patients with type 2 diabetes: a new use for an old friendJ Clin Endocrinol Metab1996812423867555510.1210/jc.81.7.24231:CAS:528:DyaK28XktFaks70%3D – reference: RiddleMFriasJZhangBPramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulinDiabetes Care200730279427991769861510.2337/dc07-05891:CAS:528:DC%2BD2sXhtlKhs7rE – reference: Diabetes Prevention Program Research GroupImpact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention ProgramDiabetes Care20052888889410.2337/diacare.28.4.888 – reference: HeineRJVan GaalLFJohnsDMihmMJWidelMHBrodowsRGExenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetesAnn Int Med2005143559569162307221:CAS:528:DC%2BD2MXhtF2qsrnE – reference: Van de Laar FA, Lucassen PL, Akkermans RP et al (2005) Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2:CD003639 – reference: KahnSEHaffnerSMHeiseMAADOPT Study GroupGlycemic durability of rosiglitazone, metformin, or glyburide monotherapyN Engl J Med2006355242724431714574210.1056/NEJMoa0662241:CAS:528:DC%2BD28Xht12ntrzF – reference: GangjiASCukiermanTGersteinHCGoldsmithCHClaseCMA systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulinDiabetes Care200730389941725951810.2337/dc06-1789 – reference: UK Prospective Diabetes Study (UKPDS) GroupIntensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33)Lancet199835283785310.1016/S0140-6736(98)07019-6 – reference: The Action to Control Cardiovascular Risk in Diabetes Study GroupEffects of intensive glucose lowering in type 2 diabetesN Engl J Med20083582545255910.1056/NEJMoa0802743 – reference: Yki-JarvinenHDrug therapy: thiazolidinedionesN Engl J Med200435111061535630810.1056/NEJMra041001 – reference: DruckerDJBiologic actions and therapeutic potential of the proglucagon-derived peptidesNature Endocrinol Metab20051223110.1038/ncpendmet00171:CAS:528:DC%2BD28Xis1Sisb0%3D – reference: SjostromLLindroosAKPeltonenMSwedish Obese Subjects Study Scientific GroupLifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgeryN Engl J Med2004351268326931561620310.1056/NEJMoa035622 – reference: GerichJRaskinPJean-LouisLPurkayasthaDBaronAPRESERVE-beta: two year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metforminDiabetes Care200528209320991612347210.2337/diacare.28.9.20931:CAS:528:DC%2BD2MXhtVGntr%2FF – reference: GoldsteinBFeinglosMLuncefordJJohnsonJWilliams-HermanDSitagliptin 036 Study Group. Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetesDiabetes Care200730197919871748557010.2337/dc07-06271:CAS:528:DC%2BD2sXpsleksr8%3D – reference: American Diabetes Association. Standards of medical care in diabetesDiabetes Care200831Suppl 1S12S54 – reference: BuseJBHenryRRHanJKimDDFinemanMSBaronADExenatide-113 Clinical Study Group. Effects of exenatide on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetesDiabetes Care20052726283510.2337/diacare.27.11.2628 – reference: SinghSLokeYKFurbergCDLong-term risk of cardiovascular events with rosiglitazone: a meta-analysisJAMA2007298118911951784865310.1001/jama.298.10.11891:CAS:528:DC%2BD2sXhtVGmtL3K – reference: KhanMASt PeterJVXueJLA prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazoneDiabetes Care2002257087111191912910.2337/diacare.25.4.7081:CAS:528:DC%2BD38XjtVCnsb0%3D – reference: MalaisseWJPharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitusTreat Endocrinol200324014141598194410.2165/00024677-200302060-000041:CAS:528:DC%2BD3sXhtVSjsbrL – reference: ChiassonJLJosseRGGomisRHanefeldMKarasikALaaksoMAcarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM TrialJAMA20032904864941287609110.1001/jama.290.4.4861:CAS:528:DC%2BD3sXls1yjs7c%3D – reference: GroopLSulfonylureas in NIDDMDiabetes Care199215737747160083410.2337/diacare.15.6.7371:STN:280:DyaK383ovFCitg%3D%3D – reference: MeinertCLKnatterudGLProutTEKlimtCRThe University Group Diabetes Program: a study of the effect of hypoglycemic agents on vascular complications in patients with adult-onset diabetesII Mortality results. Diabetes197019Suppl 1789830 – reference: SalpeterSGreyberEPasternakGSalpeterERisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusCochrane Database Syst. Rev.20061CD00296716437448 – reference: DaileyGRosenstockJMosesRGWaysKInsulin glulisine provides improved glycemic control in patients with type 2 diabetesDiabetes Care200427236323681545190110.2337/diacare.27.10.23631:CAS:528:DC%2BD2cXovFOmtbs%3D – reference: Abraira C, Duckworth WC, Moritz T (2008) Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report. Diabetes Obes Metab. doi:10.1111/j.1463-1326.2008.00933.x – reference: StrattonIMAdlerAINeilHAAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ20003214054121093804810.1136/bmj.321.7258.4051:STN:280:DC%2BD3cvisFWnsg%3D%3D – reference: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research GroupIntensive diabetes therapy and carotid intima–media thickness in type 1 diabetesN Engl J Med20033482294230310.1056/NEJMoa022314 – reference: GrundySMCleemanJIMerzNBImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation20041102272391524951610.1161/01.CIR.0000133317.49796.0E – reference: NathanDMBuseJBDavidsonMBManagement of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapyUpdate regarding the thiazolidinediones. Diabetologia2008518111:STN:280:DC%2BD2sjgvFGktA%3D%3D – reference: Yki-JarvinenHRyysyLNikkilaKTulokasTVanamoRHeikkilaMComparison of bedtime insulin regimens in patients with type 2 diabetes mellitusAnn Int Med1999130389396100684121:CAS:528:DyaK1MXhsl2htrY%3D – reference: DamsboPClausonPMarburyTCWindfeldKA double blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patientsDiabetes Care1999227897941033268310.2337/diacare.22.5.7891:STN:280:DyaK1M3msFSrtQ%3D%3D – reference: AmoriRELauJPittasAGEfficacy and safety of incretin therapy in type 2 diabetes: a systematic review and meta-analysisJAMA20072981942061762260110.1001/jama.298.2.1941:CAS:528:DC%2BD2sXnslSjuro%3D – reference: RaskinPAllenEHollanderPInitiating insulin therapy in type 2 diabetesDiabetes Care2005282602651567777610.2337/diacare.28.2.2601:CAS:528:DC%2BD2MXhsFOmsrc%3D – reference: OhkuboYKishikawaHArakiEIntensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with NIDDM: A randomized prospective 6-year studyDiab Res Clin Pract19952810311710.1016/0168-8227(95)01064-K1:CAS:528:DyaK2MXpsVWgtrs%3D – reference: ZammittNNFrierBMHypoglycemia in type 2 diabetesDiabetes Care200528294829611630656110.2337/diacare.28.12.2948 – reference: UK Prospective Diabetes Study (UKPDS) GroupEffect of intensive blood glucose control with metformin on complication in overweight patients with type 2 diabetes (UKPDS 34)Lancet199835285486510.1016/S0140-6736(98)07037-8 – reference: FarmerAWadeAGoyderEImpact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trialBMJ20073351321759162310.1136/bmj.39247.447431.BE – reference: UKPDS GroupUK Prospective Diabetes Study 16: overview of six years’ therapy of type 2 diabetes: a progressive diseaseDiabetes1995441249125810.2337/diabetes.44.11.1249 – reference: European Diabetes Policy GroupA desk-top guide to type 2 diabetes mellitusDiabet Med19991671673010.1046/j.1464-5491.1999.00166.x – reference: SheehanMTCurrent therapeutic options in type 2 diabetes mellitus: a practical approachClin Med Res200311892001593130910.3121/cmr.1.3.189 – reference: HolsteinAPlaschkeAEgbertsE-HLower incidence of severe hypoglycemia in patients with type 2 diabetes treated with glimepiride versus glibenclamideDiabetes Metab Res Rev2001174674731175708310.1002/dmrr.2351:CAS:528:DC%2BD38XnsFSkug%3D%3D – reference: ChaseHPJacksonWEHoopsSLCockerhamRSArcherPGO’BrienDGlucose control and the renal and retinal complications of insulin-dependent diabetesJAMA1989261115560291543710.1001/jama.261.8.11551:STN:280:DyaL1M7isFygsg%3D%3D – reference: HarrisMIEpidemiologic correlates of NIDDM in Hispanics, whites and blacks in the U.Spopulation. Diabetes Care199114Suppl 363964810.2337/diacare.14.7.6391:STN:280:DyaK38%2FgslSlsQ%3D%3D – reference: WengJLiYXuWEffect of intensive insulin therapy on beta-cell function and glycemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomized parallel-group trialLancet2008371175317601850229910.1016/S0140-6736(08)60762-X1:CAS:528:DC%2BD1cXmt1Ontr4%3D – reference: MeierCKraenzlinMEBodmerMJickSSJickHMeierCRUse of thiazolidinediones and fracture riskArch Intern Med20081688208251844325610.1001/archinte.168.8.8201:CAS:528:DC%2BD1cXmtFSrsLg%3D – reference: KendallDMRiddleMCRosenstockJEffects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylureaDiabetes Care200528108310911585557110.2337/diacare.28.5.10831:CAS:528:DC%2BD2MXksF2hu7s%3D – reference: National Institute for Clinical Excellence (2002) Clinical guidelines for type 2 diabetes mellitus: management of blood glucose. London, NICE. Available from http://www.nice.org.uk/Guidance/CG66 – reference: WelschenLMCBloemendalENijpelsGSelf-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic reviewDiabetes Care200528151015171592008310.2337/diacare.28.6.1510 – reference: SinghSLokeYKFurbergCDThiazolidinediones and heart failure: a teleoanalysisDiabetes Care2007302248225410.2337/dc07-01411:CAS:528:DC%2BD2sXpsleksLw%3D – reference: RewersMHammanRFHarrisMRisk factors for non-insulin dependent diabetesDiabetes in America, 2nd ed. NIH Publication No. 95–14681995BethesdaNational Institutes of Health179220 – reference: HomePDPocockSJBeck-NielsenHRECORD Study GroupRosiglitazone evaluated for cardiovascular outcomes—an interim analysisN Engl J Med200735728381755115910.1056/NEJMoa0733941:CAS:528:DC%2BD2sXnsVCqs7w%3D – reference: SchmitzOBrockBRungbyJAmylin agonists: a novel approach in the treatment of diabetesDiabetes200453Suppl 3S2332381556191710.2337/diabetes.53.suppl_3.S2331:CAS:528:DC%2BD2cXhtVOls7vL – reference: MonamiMLamannacCMarchionniNMannucciEComparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysisDiabetes Res Clin Pract2008791962031793173310.1016/j.diabres.2007.08.0241:CAS:528:DC%2BD1cXhsVKisbk%3D – reference: ShawJSWilmotRLKilpatrickESEstablishing pragmatic estimated GFR thresholds to guide metformin prescribingDiabetic Medicine200724116011631767286010.1111/j.1464-5491.2007.02221.x1:STN:280:DC%2BD2srmslSksQ%3D%3D – volume: 358 start-page: 2560 year: 2008 ident: 1157_CR12 publication-title: N Engl J Med doi: 10.1056/NEJMoa0802987 – volume: 346 start-page: 393 year: 2002 ident: 1157_CR50 publication-title: N Engl J Med doi: 10.1056/NEJMoa012512 – volume: 222 start-page: 339 year: 1995 ident: 1157_CR42 publication-title: Ann Surg doi: 10.1097/00000658-199509000-00011 – volume: 25 start-page: 1410 year: 2002 ident: 1157_CR38 publication-title: Diabetes Care doi: 10.2337/diacare.25.8.1410 – volume: 49 start-page: 2564 year: 2006 ident: 1157_CR83 publication-title: Diabetologia doi: 10.1007/s00125-006-0416-z – volume: 347 start-page: 1342 year: 2002 ident: 1157_CR15 publication-title: N Engl J Med doi: 10.1056/NEJMcp021106 – volume: 261 start-page: 1155 year: 1989 ident: 1157_CR19 publication-title: JAMA doi: 10.1001/jama.1989.03420080075034 – volume: 47 start-page: 1985 year: 2001 ident: 1157_CR20 publication-title: Clin Chem – volume: 298 start-page: 194 year: 2007 ident: 1157_CR35 publication-title: JAMA doi: 10.1001/jama.298.2.194 – volume: 30 start-page: 389 year: 2007 ident: 1157_CR54 publication-title: Diabetes Care doi: 10.2337/dc06-1789 – volume: 358 start-page: 2545 year: 2008 ident: 1157_CR11 publication-title: N Engl J Med doi: 10.1056/NEJMoa0802743 – volume: 289 start-page: 2560 year: 2003 ident: 1157_CR22 publication-title: JAMA doi: 10.1001/jama.289.19.2560 – ident: 1157_CR25 – volume: 30 start-page: 2248 year: 2007 ident: 1157_CR62 publication-title: Diabetes Care doi: 10.2337/dc07-0141 – volume: 28 start-page: 103 year: 1995 ident: 1157_CR8 publication-title: Diab Res Clin Pract doi: 10.1016/0168-8227(95)01064-K – volume: 333 start-page: 541 year: 1995 ident: 1157_CR49 publication-title: N Engl J Med doi: 10.1056/NEJM199508313330902 – volume: 352 start-page: 854 year: 1998 ident: 1157_CR7 publication-title: Lancet doi: 10.1016/S0140-6736(98)07037-8 – volume: 147 start-page: 386 year: 2007 ident: 1157_CR37 publication-title: Ann Intern Med doi: 10.7326/0003-4819-147-6-200709180-00178 – volume: 2 start-page: CD005613 year: 2007 ident: 1157_CR71 publication-title: Cochrane Database Syst Rev – ident: 1157_CR29 doi: 10.1002/14651858.CD003639.pub2 – volume: 108 start-page: 334 year: 1988 ident: 1157_CR74 publication-title: Ann Int Med doi: 10.7326/0003-4819-108-3-334 – volume: 335 start-page: 132 year: 2007 ident: 1157_CR86 publication-title: BMJ doi: 10.1136/bmj.39247.447431.BE – volume: 130 start-page: 389 year: 1999 ident: 1157_CR92 publication-title: Ann Int Med doi: 10.7326/0003-4819-130-5-199903020-00002 – volume: 348 start-page: 2294 year: 2003 ident: 1157_CR9 publication-title: N Engl J Med doi: 10.1056/NEJMoa022314 – start-page: 179 volume-title: Diabetes in America, 2nd ed. NIH Publication No. 95–1468 year: 1995 ident: 1157_CR40 – volume: 79 start-page: 196 year: 2008 ident: 1157_CR36 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2007.08.024 – volume: 161 start-page: 1653 year: 2005 ident: 1157_CR77 publication-title: Arch Int Med doi: 10.1001/archinte.161.13.1653 – volume: 371 start-page: 1753 year: 2008 ident: 1157_CR88 publication-title: Lancet doi: 10.1016/S0140-6736(08)60762-X – volume: 24 start-page: 1160 year: 2007 ident: 1157_CR52 publication-title: Diabetic Medicine doi: 10.1111/j.1464-5491.2007.02221.x – volume: 22 start-page: 789 year: 1999 ident: 1157_CR59 publication-title: Diabetes Care doi: 10.2337/diacare.22.5.789 – volume: 27 start-page: 2628 year: 2005 ident: 1157_CR80 publication-title: Diabetes Care doi: 10.2337/diacare.27.11.2628 – volume: 353 start-page: 2643 year: 2005 ident: 1157_CR10 publication-title: N Eng J Med doi: 10.1056/NEJMoa052187 – volume: 321 start-page: 405 year: 2000 ident: 1157_CR24 publication-title: BMJ doi: 10.1136/bmj.321.7258.405 – volume: 299 start-page: 316 year: 2008 ident: 1157_CR44 publication-title: JAMA – volume: 28 start-page: 2948 year: 2005 ident: 1157_CR76 publication-title: Diabetes Care doi: 10.2337/diacare.28.12.2948 – ident: 1157_CR3 – volume: 20 start-page: 1353 year: 1997 ident: 1157_CR87 publication-title: Diabetes Care doi: 10.2337/diacare.20.9.1353 – volume: 26 start-page: 2238 year: 2003 ident: 1157_CR91 publication-title: Diabetes Care doi: 10.2337/diacare.26.8.2238 – volume: 14 start-page: 639 issue: Suppl 3 year: 1991 ident: 1157_CR39 publication-title: population. Diabetes Care doi: 10.2337/diacare.14.7.639 – ident: 1157_CR1 doi: 10.2337/dc08-S012 – volume: 168 start-page: 820 year: 2008 ident: 1157_CR70 publication-title: Arch Intern Med doi: 10.1001/archinte.168.8.820 – volume: 28 start-page: 1547 year: 2005 ident: 1157_CR64 publication-title: Diabetes Care doi: 10.2337/diacare.28.7.1547 – volume: 27 start-page: 1265 year: 2004 ident: 1157_CR57 publication-title: Diabetes Care doi: 10.2337/diacare.27.6.1265 – volume: 298 start-page: 1189 year: 2007 ident: 1157_CR66 publication-title: JAMA doi: 10.1001/jama.298.10.1189 – volume: 28 start-page: 1510 year: 2005 ident: 1157_CR85 publication-title: Diabetes Care doi: 10.2337/diacare.28.6.1510 – volume: 28 start-page: 2093 year: 2005 ident: 1157_CR58 publication-title: Diabetes Care doi: 10.2337/diacare.28.9.2093 – volume: 28 start-page: 888 year: 2005 ident: 1157_CR46 publication-title: Diabetes Care doi: 10.2337/diacare.28.4.888 – volume: 1 start-page: 189 year: 2003 ident: 1157_CR16 publication-title: Clin Med Res doi: 10.3121/cmr.1.3.189 – volume: 25 start-page: 708 year: 2002 ident: 1157_CR63 publication-title: Diabetes Care doi: 10.2337/diacare.25.4.708 – volume: 15 start-page: 737 year: 1992 ident: 1157_CR26 publication-title: Diabetes Care doi: 10.2337/diacare.15.6.737 – volume: 27 start-page: 2363 year: 2004 ident: 1157_CR73 publication-title: Diabetes Care doi: 10.2337/diacare.27.10.2363 – volume: 143 start-page: 559 year: 2005 ident: 1157_CR81 publication-title: Ann Int Med doi: 10.7326/0003-4819-143-8-200510180-00006 – volume: 351 start-page: 1106 year: 2004 ident: 1157_CR31 publication-title: N Engl J Med doi: 10.1056/NEJMra041001 – volume: 351 start-page: 2683 year: 2004 ident: 1157_CR43 publication-title: N Engl J Med doi: 10.1056/NEJMoa035622 – volume: 352 start-page: 837 year: 1998 ident: 1157_CR6 publication-title: Lancet doi: 10.1016/S0140-6736(98)07019-6 – volume: 44 start-page: 968 year: 1995 ident: 1157_CR23 publication-title: Diabetes doi: 10.2337/diab.44.8.968 – volume: 355 start-page: 2427 year: 2006 ident: 1157_CR55 publication-title: N Engl J Med doi: 10.1056/NEJMoa066224 – volume: 30 start-page: 2794 year: 2007 ident: 1157_CR82 publication-title: Diabetes Care doi: 10.2337/dc07-0589 – volume: 357 start-page: 28 year: 2007 ident: 1157_CR61 publication-title: N Engl J Med doi: 10.1056/NEJMoa073394 – volume: 44 start-page: 1249 year: 1995 ident: 1157_CR89 publication-title: Diabetes doi: 10.2337/diab.44.11.1249 – volume: 290 start-page: 486 year: 2003 ident: 1157_CR60 publication-title: JAMA doi: 10.1001/jama.290.4.486 – volume: 298 start-page: 1180 year: 2007 ident: 1157_CR68 publication-title: JAMA doi: 10.1001/jama.298.10.1180 – volume: 30 start-page: 1979 year: 2007 ident: 1157_CR84 publication-title: Diabetes Care doi: 10.2337/dc07-0627 – volume: 329 start-page: 304 year: 1993 ident: 1157_CR5 publication-title: N Engl J Med doi: 10.1056/NEJM199307293290502 – volume: 17 start-page: 467 year: 2001 ident: 1157_CR53 publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.235 – volume: 23 start-page: 78 year: 2005 ident: 1157_CR90 publication-title: Clinical Diabetes doi: 10.2337/diaclin.23.2.78 – volume: 28 start-page: 1083 year: 2005 ident: 1157_CR78 publication-title: Diabetes Care doi: 10.2337/diacare.28.5.1083 – volume: 3 start-page: 276 year: 1975 ident: 1157_CR47 publication-title: BMJ doi: 10.1136/bmj.3.5978.276 – volume: 81 start-page: 2423 year: 1996 ident: 1157_CR48 publication-title: J Clin Endocrinol Metab – volume: 2 start-page: 401 year: 2003 ident: 1157_CR28 publication-title: Treat Endocrinol doi: 10.2165/00024677-200302060-00004 – volume: 13 start-page: 1240 year: 1990 ident: 1157_CR30 publication-title: Diabetes Care doi: 10.2337/diacare.13.12.1240 – volume: 356 start-page: 2457 year: 2007 ident: 1157_CR65 publication-title: N Engl J Med doi: 10.1056/NEJMoa072761 – volume: 110 start-page: 227 year: 2004 ident: 1157_CR21 publication-title: Circulation doi: 10.1161/01.CIR.0000133317.49796.0E – volume: 1 start-page: 22 year: 2005 ident: 1157_CR32 publication-title: Nature Endocrinol Metab doi: 10.1038/ncpendmet0017 – volume: 287 start-page: 360 year: 2002 ident: 1157_CR17 publication-title: JAMA doi: 10.1001/jama.287.3.360 – ident: 1157_CR34 doi: 10.1002/14651858.CD006739.pub2 – volume: 51 start-page: 8 year: 2008 ident: 1157_CR69 publication-title: Update regarding the thiazolidinediones. Diabetologia doi: 10.1007/s00125-007-0873-z – volume: 28 start-page: 2703 year: 2005 ident: 1157_CR45 publication-title: Diabetes Care doi: 10.2337/diacare.28.11.2703 – volume: 334 start-page: 574 year: 1996 ident: 1157_CR27 publication-title: N Engl J Med doi: 10.1056/NEJM199602293340906 – volume: 18 start-page: 1113 year: 1995 ident: 1157_CR75 publication-title: Diabetes Care doi: 10.2337/diacare.18.8.1113 – volume: 28 start-page: 1092 year: 2005 ident: 1157_CR79 publication-title: Diabetes Care doi: 10.2337/diacare.28.5.1092 – volume: 260 start-page: 2864 year: 1988 ident: 1157_CR18 publication-title: JAMA doi: 10.1001/jama.1988.03410190112033 – volume: 329 start-page: 978 year: 1993 ident: 1157_CR4 publication-title: N Engl J Med – volume: 366 start-page: 1279 year: 2005 ident: 1157_CR67 publication-title: Lancet doi: 10.1016/S0140-6736(05)67528-9 – volume: 28 start-page: 260 year: 2005 ident: 1157_CR72 publication-title: Diabetes Care doi: 10.2337/diacare.28.2.260 – volume: 19 start-page: 789 issue: Suppl 1 year: 1970 ident: 1157_CR56 publication-title: II Mortality results. Diabetes – volume: 16 start-page: 716 year: 1999 ident: 1157_CR2 publication-title: Diabet Med doi: 10.1046/j.1464-5491.1999.00166.x – volume: 53 start-page: S233 issue: Suppl 3 year: 2004 ident: 1157_CR33 publication-title: Diabetes doi: 10.2337/diabetes.53.suppl_3.S233 – volume: 1 start-page: CD002967 year: 2006 ident: 1157_CR51 publication-title: Cochrane Database Syst. Rev. – volume: 356 start-page: 437 year: 2007 ident: 1157_CR14 publication-title: N Engl J Med doi: 10.1056/NEJMp068294 – ident: 1157_CR13 doi: 10.1111/j.1463-1326.2008.00933.x – volume: 30 start-page: 1374 year: 2007 ident: 1157_CR41 publication-title: Diabetes Care doi: 10.2337/dc07-0048 – reference: 17622601 - JAMA. 2007 Jul 11;298(2):194-206 – reference: 3184351 - JAMA. 1988 Nov 18;260(19):2864-71 – reference: 1148773 - Br Med J. 1975 Aug 2;3(5978):276-8 – reference: 15855571 - Diabetes Care. 2005 May;28(5):1083-91 – reference: 18671796 - Diabetes Obes Metab. 2009 Feb;11(2):150-6 – reference: 18425967 - Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006739 – reference: 8675555 - J Clin Endocrinol Metab. 1996 Jul;81(7):2423-7 – reference: 19107458 - Diabetologia. 2009 Mar;52(3):552-3; author reply 554-5 – reference: 15983299 - Diabetes Care. 2005 Jul;28(7):1547-54 – reference: 19259643 - Diabetologia. 2009 May;52(5):986-7 – reference: 8366922 - N Engl J Med. 1993 Sep 30;329(14 ):977-86 – reference: 16230722 - Ann Intern Med. 2005 Oct 18;143(8):559-69 – reference: 7587846 - Diabetes Care. 1995 Aug;18(8):1113-23 – reference: 9283777 - Diabetes Care. 1997 Sep;20(9):1353-6 – reference: 17517853 - N Engl J Med. 2007 Jun 14;356(24):2457-71 – reference: 15161773 - Diabetes Care. 2004 Jun;27(6):1265-70 – reference: 1914813 - Diabetes Care. 1991 Jul;14(7):639-48 – reference: 18539917 - N Engl J Med. 2008 Jun 12;358(24):2545-59 – reference: 18539916 - N Engl J Med. 2008 Jun 12;358(24):2560-72 – reference: 16437448 - Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002967 – reference: 12145243 - Diabetes Care. 2002 Aug;25(8):1410-7 – reference: 15981944 - Treat Endocrinol. 2003;2(6):401-14 – reference: 8569826 - N Engl J Med. 1996 Feb 29;334(9):574-9 – reference: 15846673 - Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003639 – reference: 17267901 - N Engl J Med. 2007 Feb 1;356(5):437-40 – reference: 4926376 - Diabetes. 1970;19:Suppl:789-830 – reference: 15356308 - N Engl J Med. 2004 Sep 9;351(11):1106-18 – reference: 15793191 - Diabetes Care. 2005 Apr;28(4):888-94 – reference: 15931309 - Clin Med Res. 2003 Jul;1(3):189-200 – reference: 16214598 - Lancet. 2005 Oct 8;366(9493):1279-89 – reference: 2276309 - Diabetes Care. 1990 Dec;13(12):1240-64 – reference: 1600834 - Diabetes Care. 1992 Jun;15(6):737-54 – reference: 12876091 - JAMA. 2003 Jul 23;290(4):486-94 – reference: 7677463 - Ann Surg. 1995 Sep;222(3):339-50; discussion 350-2 – reference: 15677776 - Diabetes Care. 2005 Feb;28(2):260-5 – reference: 10068412 - Ann Intern Med. 1999 Mar 2;130(5):389-96 – reference: 17638715 - Ann Intern Med. 2007 Sep 18;147(6):386-99 – reference: 17698615 - Diabetes Care. 2007 Nov;30(11):2794-9 – reference: 3124685 - Ann Intern Med. 1988 Mar;108(3):334-40 – reference: 7587918 - Diabetes Res Clin Pract. 1995 May;28(2):103-17 – reference: 16249543 - Diabetes Care. 2005 Nov;28(11):2703-9 – reference: 10510947 - Diabet Med. 1999 Sep;16(9):716-30 – reference: 17551159 - N Engl J Med. 2007 Jul 5;357(1):28-38 – reference: 9742976 - Lancet. 1998 Sep 12;352(9131):837-53 – reference: 11832527 - N Engl J Med. 2002 Feb 7;346(6):393-403 – reference: 2915437 - JAMA. 1989 Feb 24;261(8):1155-60 – reference: 11790216 - JAMA. 2002 Jan 16;287(3):360-72 – reference: 17672860 - Diabet Med. 2007 Oct;24(10):1160-3 – reference: 11434798 - Arch Intern Med. 2001 Jul 9;161(13):1653-9 – reference: 12397193 - N Engl J Med. 2002 Oct 24;347(17):1342-9 – reference: 17485570 - Diabetes Care. 2007 Aug;30(8):1979-87 – reference: 8147960 - N Engl J Med. 1993 Jul 29;329(5):304-9 – reference: 17848653 - JAMA. 2007 Sep 12;298(10):1189-95 – reference: 10332683 - Diabetes Care. 1999 May;22(5):789-94 – reference: 17931733 - Diabetes Res Clin Pract. 2008 Feb;79(2):196-203 – reference: 19513689 - Diabetologia. 2009 Aug;52(8):1696-7 – reference: 18165335 - Diabetes Care. 2008 Jan;31 Suppl 1:S12-54 – reference: 7589820 - Diabetes. 1995 Nov;44(11):1249-58 – reference: 17001471 - Diabetologia. 2006 Nov;49(11):2564-71 – reference: 20803189 - Diabetologia. 2010 Nov;53(11):2285-8 – reference: 17363746 - Diabetes Care. 2007 Jun;30(6):1374-83 – reference: 17848652 - JAMA. 2007 Sep 12;298(10):1180-8 – reference: 11757083 - Diabetes Metab Res Rev. 2001 Nov-Dec;17(6):467-73 – reference: 17443605 - Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005613 – reference: 18026926 - Diabetologia. 2008 Jan;51(1):8-11 – reference: 11919129 - Diabetes Care. 2002 Apr;25(4):708-11 – reference: 15249516 - Circulation. 2004 Jul 13;110(2):227-39 – reference: 12748199 - JAMA. 2003 May 21;289(19):2560-72 – reference: 12788993 - N Engl J Med. 2003 Jun 5;348(23 ):2294-303 – reference: 17536074 - Diabetes Care. 2007 Aug;30(8):2148-53 – reference: 7622004 - Diabetes. 1995 Aug;44(8):968-83 – reference: 17259518 - Diabetes Care. 2007 Feb;30(2):389-94 – reference: 16929363 - Nat Clin Pract Endocrinol Metab. 2005 Nov;1(1):22-31 – reference: 17145742 - N Engl J Med. 2006 Dec 7;355(23):2427-43 – reference: 15451901 - Diabetes Care. 2004 Oct;27(10):2363-8 – reference: 15561917 - Diabetes. 2004 Dec;53 Suppl 3:S233-8 – reference: 12882842 - Diabetes Care. 2003 Aug;26(8):2238-43 – reference: 11673367 - Clin Chem. 2001 Nov;47(11):1985-92 – reference: 16371630 - N Engl J Med. 2005 Dec 22;353(25):2643-53 – reference: 9813653 - Obes Res. 1998 Sep;6 Suppl 2:51S-209S – reference: 16123472 - Diabetes Care. 2005 Sep;28(9):2093-9 – reference: 18502299 - Lancet. 2008 May 24;371(9626):1753-60 – reference: 15855572 - Diabetes Care. 2005 May;28(5):1092-100 – reference: 15920083 - Diabetes Care. 2005 Jun;28(6):1510-7 – reference: 7623902 - N Engl J Med. 1995 Aug 31;333(9):541-9 – reference: 18212316 - JAMA. 2008 Jan 23;299(3):316-23 – reference: 15616203 - N Engl J Med. 2004 Dec 23;351(26):2683-93 – reference: 18443256 - Arch Intern Med. 2008 Apr 28;168(8):820-5 – reference: 10938048 - BMJ. 2000 Aug 12;321(7258):405-12 – reference: 15504997 - Diabetes Care. 2004 Nov;27(11):2628-35 – reference: 19034415 - Diabetologia. 2009 Mar;52(3):550-1; author reply 554-5 – reference: 9742977 - Lancet. 1998 Sep 12;352(9131):854-65 – reference: 17591623 - BMJ. 2007 Jul 21;335(7611):132 – reference: 16306561 - Diabetes Care. 2005 Dec;28(12):2948-61 |
| SSID | ssj0003546 |
| Score | 2.4961069 |
| Snippet | The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the... |
| SourceID | proquest pubmed pascalfrancis crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 17 |
| SubjectTerms | Algorithms Biological and medical sciences Consensus Statement Update Controlled Clinical Trials as Topic Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - psychology Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Europe Human Physiology Hyperglycemia - drug therapy Hyperglycemia - prevention & control Hyperglycemia - psychology Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use Internal Medicine Life Style Medical sciences Medicine Medicine & Public Health Metabolic Diseases Societies, Medical United States |
| Subtitle | A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9UwFD_MOxBBxG-76cyDT0qwTdKkEURUNoawITLhvpU0Sbcr9_bere3DffcPN2mTjqHuuTltOOfk5PR8_A7Am4xUhWKVwRUXBjOVMey8EO1OfFpbzSS3ZqjyPeXHP9m3eT7fgZPYC-PLKqNNHAy1WWsfI39PMlqwPOfs0-YS-6FRPrkaJ2ioMFnBfBwQxu7ALvHAWDPY_XJ4-v3HZJpp6NxxVhlnBZ_HNGc6oIq6ux4PaKdZLvD2xkV1f6Nax7N6HHbxL2_0r0zqcEEdPYQHwbNEn0dVeAQ7tnkMd09C7vwJ_A45GbSaKl7QukYX7kf06ny51cquFgotGuSjsoigGJVFK4_Z2fXtB6SQ9sXXTdu3SC3PHX-6ixVybi9ybqQjXXSjoJFqDFLmV9928TNjn9f2KZwdHZ59PcZhBgPWlMgOE-Xb5VNiC2GUoFQYYnlhKTepypQWutba2YBcGiOFNTSXFXGct7ySOuU1fQazZt3YF4ColdqvkM6CMJOLSnLj_n8qWVtR10QmkEZ-lzrgk_sxGctyQlYeRFT6uZleROU2gbcTyWYE57ht8cENIU4UxGOjSskS2I9SLcNBbstJ7RJ4PT11J9CnVVRj131b-sGpzkkrEng-qsL1XgrJMkEd7buoG9dv_u9G927dxz7cGxNaPgr0EmbdVW9fOb-oqw6Ctv8Bq-QLhQ priority: 102 providerName: ProQuest |
| Title | Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy |
| URI | https://link.springer.com/article/10.1007/s00125-008-1157-y https://www.ncbi.nlm.nih.gov/pubmed/18941734 https://www.proquest.com/docview/213845564 https://www.proquest.com/docview/66732838 |
| Volume | 52 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Food Science Source customDbUrl: eissn: 1432-0428 dateEnd: 20241102 omitProxy: false ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: A8Z dateStart: 20000101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/login.aspx?authtype=ip,uid&profile=ehost&defaultdb=fsr providerName: EBSCOhost – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1432-0428 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: AFBBN dateStart: 19970101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1432-0428 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: 7X7 dateStart: 19990101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1432-0428 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: BENPR dateStart: 19990101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1432-0428 dateEnd: 20171231 omitProxy: true ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: 8C1 dateStart: 19990101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1432-0428 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1432-0428 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7RVkJICPFmKSw-cAJFSvyMuS3VlgpEhVArLafIsZ120W622iSHvfPDGedVVRQkLsnBM4nl8difPS-AtwnNU8NzF-VSuYibhEeIQixqfFx4y7X0rvXyPZUn5_zzQiz6OO5q8HYfTJLtSj0Gu4WdWURtOtJEqGi3BwciZPPCSXxOZ-Pyy_roHKSOklQuBlPmbZ-4sRndvzIVjkvRFbS4DXH-YS1tN6Hjh_CgR49k1on7Edzx5WO4-7W3jz-BX73dhaxHrxayKcglHja3F6udNX69NGRZknDzSigZbl7JOuTlrJvqAzHEBgfrsmoqYlYXm-2yvlwThLYEoSKyLutOmMSUjhj3s6nq4TddLNfuKZwdz8-OTqK-zkJkGdV1RE0IiY-pT5UzijHlqJepZ9LFJjFW2cJa1HOhndPKOyZ0TvGk6GWubSwL9gz2y03pXwBhXttAoXGV4E6oXEuHZ5xcF14VBdUTiIfxzmyfgzyUwlhlY_bkVkRZqI0ZRJTtJvBuZLnqEnD8i3h6Q4gjBw35T7XmEzgcpJr1ylphI0u5EBJb34ytqGXBdGJKv2mqLBRHRSCWTuB5NxWu-5JqniiGvO-HuXH95b929OV_UR_Cvc6IFW5-XsF-vW38a8RCdT6FPbVQ-EyPkikczD79-DLH98f56bfv01YvfgPUIAdH |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKKwFShXg3FFof4AKKmtiOHSNViEerLW1XCC3S3iLHdtpFu9mlSYRy52fx4xjnVVVAbz0ndqzMeN7zDUIvQ5LGiqXGT7kwPlMh88EK0XDjg8xqJrk1TZXvmI--sc_TaLqGfve9MK6sspeJjaA2S-1i5HskpDGLIs7erX74bmiUS672EzRUN1nB7DcIY11fx7Gtf4IHV-wffQJyvyLk8GDyceR3QwZ8TYksfaJcP3hAbCyMEpQKQyyPLeUmUKHSQmdaA5NH0hgprKGRTAm4SZanUgc8o7DtLbTBKJPg-m18OBh_-TpoAto1CoES8MOYT_usatCAmIJp4TfgqmEk_PqKXtxcqQJIlLWzNf5l_P6VuG304eF9dK8zZPH7lvMeoDWbP0S3T7tU_SP0q0sB4cVQYIOXGT4Hv_fibF5rZRczhWc5dkFgTHAfBMYLBxFaVsVbrLB2td55URVYzc-AHOX5AoOVjcFqhaWzsuUrrHKDlfleFWX_mbatrH6MJjdBjSdoPV_mdgthaqV2b0gQWMxEIpXcgLuVysyKLCPSQ0H_vxPdwaG7qRzzZABybkiUuDGdjkRJ7aHXw5JViwVy3cs7V4g4rCAOilVK5qHtnqpJJzeKZOByD-0OT-HCuyyOyu2yKhI3pxVswthDT1tWuDxLLFkoKKx90_PG5c7_Peiza8-xi-6MJqcnycnR-Hgb3W1zaS4A9RytlxeVfQEmWZnudJyPUXLDd-0PeB1H4w |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKVCEhxJtQaH2AC8hqYid2jIQQoqxaChWHIu0tcmynXbSbXZpEaO98FJ_HOK-qAnrrOR7H8jw87wF4EbE81XFuaS6kpbGOYopaiEGODwtnYiWcbbN8j8XBt_jTNJluwO-hFsanVQ4ysRXUdmm8j3yPRTyNk0TEe0WfFfF1f_Ju9YP6AVI-0DpM0-go5Mitf6L1Vr093EdUv2Rs8vHkwwHtBwxQw5mqKdO-FjxkLpVWS86lZU6kjgsb6kgbaQpjkMATZa2SzvJE5QxNJCdyZUJRcNz2BtxEQOWTCeV0NPVC3pcIofinUSqmQzw1bNuXolJB27aqUSLp-tKLeHulK0RO0U3V-Jfa-1fItn0JJ3fhTq_Ckvcdzd2DDVfeh60vfZD-Afzqgz9kMabWkGVBztDiPT-dr412i5kms5J49y9hZHD_koVvDlo31RuiifFZ3mXVVETPT_Hy67MFQf2aoL6KoLO6oyiiS0u0_d5U9fCbrqBs_RBOrgMXj2CzXJbuCRDulPErFIqq2CYyV8KioZWrwsmiYCqAcLjvzPSN0P08jnk2tnBuUZT5AZ0eRdk6gFcjyKrrAnLV4p1LSBwhmG_CqlQcwPaA1ayXGFU20ncAu-NXZHUfv9GlWzZV5ie0ojaYBvC4I4WLs6QqjiRH2NcDbVzs_N-DPr3yHLuwhRyWfT48PtqGW10QzXuensFmfd6456iL1flOS_YEsmtmsz96EkV9 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Medical+management+of+hyperglycaemia+in+type+2+diabetes+mellitus%3A+a+consensus+algorithm+for+the+initiation+and+adjustment+of+therapy+%3A+A+consensus+statement+from+the+American+Diabetes+Association+and+the+European+Association+for+the+Study+of+Diabetes&rft.jtitle=Diabetologia&rft.au=NATHAN%2C+D.+M&rft.au=BUSE%2C+J.+B&rft.au=DAVIDSON%2C+M.+B&rft.au=FERRANNINI%2C+E&rft.date=2009&rft.pub=Springer&rft.issn=0012-186X&rft.volume=52&rft.issue=1&rft.spage=17&rft.epage=30&rft_id=info:doi/10.1007%2Fs00125-008-1157-y&rft.externalDBID=n%2Fa&rft.externalDocID=21091994 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-186X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-186X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-186X&client=summon |